Skip to main content
PLOS One logoLink to PLOS One
. 2025 Mar 17;20(3):e0318576. doi: 10.1371/journal.pone.0318576

Menstrual cycle effects on cognitive performance: A meta-analysis

Daisung Jang 1,*, Jack Zhang 2, Hillary Anger Elfenbein 3
Editor: Ayman A Swelum4
PMCID: PMC11913300  PMID: 40096188

Abstract

Does a woman’s cognitive performance change throughout her menstrual cycle? Menstruation continues to be a taboo topic, subject to myths about how it affects women. Despite the considerable number of empirical studies, there have been few quantitative summaries of what is known. To address this gap, we conducted a meta-analysis of cognitive performance across the menstrual cycle, including the domains of attention, creativity, executive functioning, intelligence, motor function, spatial ability, and verbal ability. We included studies that measured women’s performance at specific points in the cycle for tasks that have objectively correct responses. Our analysis examined performance differences across phases using Hedges’ g as the effect size metric. Across 102 articles, N =  3,943 participants, and 730 comparisons, we observe no systematic robust evidence for significant cycle shifts in performance across cognitive performance. Although two results appeared significant with respect to differences in spatial ability, they arise from a large number of statistical tests and are not supported in studies that use robust methods to determine cycle phase. Through the use of Egger’s test, and examination of funnel plots, we did not observe evidence of publication bias or small-study effects. We examined speed and accuracy measures separately within each domain, and no robust differences across phases appeared for either speed or accuracy. We conclude that the body of research in this meta-analysis does not support myths that women’s cognitive abilities change across the menstrual cycle. Future research should use larger sample sizes and consistent definitions of the menstrual cycle, using hormonal indicators to confirm cycle phase.

Introduction

Women’s cognitive performance and the menstrual cycle

Women’s cognitive performance throughout the menstrual cycle has been the topic of much writing and speculation. Menstruation in particular is often treated like a disease, impairing women’s ability to function [1]. In 1988, the front page of the New York Times featured a story with the headline “Female sex hormone is tied to ability to perform tasks” [2]. More recently, during the 2016 US presidential election, a letter to a newspaper editor speculated about candidate Hillary Rodham Clinton’s ability to be president during “that time of month”, despite her age strongly suggesting she had reached menopause [3]. In this meta-analysis, we examine the role of the menstrual cycle on women’s cognitive performance, by conducting the most comprehensive meta-analysis on the topic to date, including in the domains of attention, creativity, executive functioning, intelligence, memory, motor function, spatial, and verbal ability, and measures of speed and accuracy in each case. Doing so allows us to address prominent limitations faced in this line of research and robustly examine the existing evidence.

Attitudes about the menstrual cycle

Attitudes about and practices around the menstrual cycle can have detrimental impacts on women’s ability to function. Menstruation is a taboo topic across many cultures, often associated with shame and misinformation [4]. Advertisements of sanitary products associate menses with themes of impediment and denial [5]. The idea of impaired functioning around menstruation has merit, based on societal resources afforded to women. Especially for those with low socioeconomic status, obtaining menstrual products can be a strain on time and resources. Obtaining menstrual products is accompanied by belittling attitudes and need for bathroom access that can be limited [6]. Such factors apply to varying degrees around the world. A systematic review and meta-analysis of menstrual knowledge and practices in India also illustrate numerous challenges for women, including being forbidden to take part in religious activities, cooking, exercise, recreation, and household activities [7]. Menstruating women also face isolation, restricted movement, and restrictions on attending social functions. In fact, only 13% of Indian women report facing no restrictions. Only a quarter of girls in India know that the uterus is the source of menstrual blood [7], which is significant because accurate knowledge about menstruation is associated with better menstrual hygiene [8]. Lack of knowledge about menstruation is prevalent across multiple cultures, particularly in low and middle income nations [9]. Such attitudes also exist in developed countries. A representative survey of over 1000 people in the US by the Tampax Corporation revealed that 35% of people believe menstruation impacts a woman’s ability to think, and 26% believe women cannot function as well when menstruating [10]. Similarly, a review that examined data from university students revealed menstruation negatively impacts functioning across both low and high income countries, as women internalize menstrual stigma [8]. Attitudes and practices at both the societal and individual levels have varied across history and cultures [11,12], and can impact women’s ability to function.

There are also largely negative messages communicated by individuals. Examining nearly 10,000 tweets reveals that most women sending tweets on the topic of menstruation included themes of impaired health, experience of symptoms, and stigma [13]. And although in the minority, there were also contrasting sentiments of positivity, with 14% of tweets featuring themes of strength and resilience, as well as combatting misconceptions [13], suggesting that menstruation is not always a negative experience.

In this paper we ask about the cycle’s impact on women’s ability to think in terms of measures that have objectively correct vs. incorrect answers. In the following sections we survey existing research on the menstrual cycle and cognitive performance, both in terms of measuring women’s subjective experiences, and research that measures objective cognitive ability.

Evidence for fluctuations in cognitive performance across the cycle

Women’s reports of subjective experience would suggest that cognitive performance may fluctuate across the cycle. From the earliest attempts to measure menstrual symptoms systematically, researchers have documented significant shifts in the subjective ability to concentrate and perform, particularly around the premenstrual and menstrual phases [1416]. Englander-Golden and colleagues [14] note that retrospective recalls of fluctuation throughout the cycle tend to be greater than the day-to-day reports of fluctuation, which suggests that lay theory exaggerates the magnitude of self-reported cycle effects. Even with the concern about the subjective nature of self-reports, these findings suggest the possibility of shifts in the ability to focus and undertake cognitive ability tasks across the menstrual cycle. Next, we discuss cycle related shifts in brain morphology. We do so because there is a lack of research around mechanisms that directly link cognitive performance and the menstrual cycle, but changes in morphology could impact performance through secondary mechanisms, such as fluctuations in neural connectivity.

Brain imaging studies reveal shifts in morphology that complement subjective reports. Although the total volume of grey matter does not change across the cycle, localized regions show fluctuations [17,18], which correspond with subjective experiences. Fluctuations in grey matter volume in the amygdala correspond with the experience of greater negative affect from the follicular to the premenstrual phase [19]. Likewise, changes in grey matter volume in the caudate nucleus, hypothalamus, and thalamus tend to be associated with menstrual pain experience [20]. Such shifts in morphology apply to regions of the brain that are implicated in cognitive performance, which implies a potential mechanism for menstrual cycle effects on cognition. The grey matter volume in the hippocampus, a region associated with memory, increases from the premenstrual/ follicular to later phases [21,22]. This increase in hippocampus grey matter is accompanied by increased connectivity to surrounding regions [22]. When examining the entire brain, a small-scale study revealed fluctuations in patterns of atrophy across the cycle. Compared to menses, ovulation resulted in lower measured atrophy [18]. These findings are indicative of plasticity in brain structure across the cycle and suggest there could be accompanying shifts in measured cognitive ability.

Further suggestive evidence for performance differences across the cycle is evident in functional magnetic resonance imaging (fMRI) research. In this work, menstrual cycle fluctuations in estradiol and progesterone also correspond to changes in brain activity [23,24]. Activity levels of the orbital frontal cortex fluctuate with the menstrual cycle, and also correlate with changes in processing emotional stimuli [25]. In another example, increased activity between the dorsal striatum correlated with greater responsiveness to short term rewards in the follicular vs. luteal phase as demonstrated through delay-discounting tasks [26]. Moreover, multiple areas of the brain feature estrogen receptors, including the hypothalamus, amygdala, and hippocampus [27], suggesting fluctuating hormones may have an impact on their function. Taken together, these findings are consistent with the possibility of menstrual cycle effects on cognitive functioning.

Evidence against fluctuations in cognitive ability across the cycle

In contrast with the view that the menstrual cycle influences cognitive performance, multiple narrative reviews of the existing literature on menstruation and women’s cognitive performance conclude it has little impact. Noting that the discussion of the topic was dominated by informal theories and superstition as early as 1944, Seward [28] reviewed the available evidence and concluded there were little to no performance fluctuations across the cycle in both cognitive and physical tasks. Subsequent investigations reached similar conclusions [e.g., 29] as did successive reviews of the literature [10,2932], with either null, small, or inconsistent patterns of menstrual cycle shifts in cognitive performance. Some disputed findings have reported fluctuations in cognitive ability in sexually dimorphic tasks [27,33]. The claim was that women perform better on verbal, motor, memory, and perception tasks during the luteal phase and that they perform better on visual memory, mathematic, and spatial tasks during menses. This conclusion was challenged in a later review, which did not reveal such patterns when examining the highest quality measurements to verify menstrual phase, such as those using hormone assay or basal body temperature [34]. The more recent review included a small-scale meta-analysis of six studies that showed no improvement in mental rotation accuracy during phases that feature lower levels of estrogen and progesterone. We note that to our knowledge these narrative reviews and the small-scale meta-analysis comprise all attempts to summarize the body of research to date. The current study quantitatively analyzes cognitive performance across multiple domains of cognition, with the intended contribution to provide a comprehensive synthesis using robust methods.

To support the idea that cognitive ability does not fluctuate across the cycle, some imaging studies show no changes in ability despite changes in brain activity. For example, despite changes in susceptibility to stress and negative affect between follicular and luteal phases and the accompanying change in amygdala activity, women did not differ in reaction time in an attention task [35]. Further, despite changes in activation in the dorsolateral prefrontal cortex, which is implicated in verbal and spatial memory [36], no differences in navigation and verbal fluency were observed across menses, preovulatory, and luteal phases [23]. Similarly, fluctuations in superior and inferior parietal cortex, implicated in spatial ability, did not translate to differences in mental rotation performance across follicular and midluteal phases [24]. The lack of correspondence between physiological changes during the cycle to cognitive performance was previously observed in this literature. In a foundational study, Schmidt and colleagues [37] demonstrated that women who had high vs. low menstrual symptoms did not differ in the level of endogenous levels estrogen and progesterone.

Evaluating the conflicting evidence amidst methodological issues

There are methodological concerns that make it challenging to evaluate the conflicting evidence in the literature. A long standing limitation in this area of research is that sample sizes are typically small, with studies sometimes reporting fewer than 10 participants [27,34]. Other challenges include inconsistent definition of cycle phases into date ranges [33,34,38,39] and reliance on self-reports of cycle phase [30] that are not reliable indicators of endocrine and other physiological changes [32]. Thus, evaluating claims about the menstrual cycle and cognitive performance would benefit from a meta-analytical approach that identifies a diverse set of studies, which is the goal of the present paper.

To address these limitations, we adopted a meta-analytic approach that encompasses major domains of cognition identified in prior research [40], including attention, creativity, executive functioning, intelligence, memory, motor function, spatial, and verbal ability. To compare cycle phases, we estimated Hedges’ g, an effect size indicator that can account for small sample sizes. To estimate effects robustly across cycle phases, we conduct subset analyses with studies that use the authoritative definitions of the cycle established in the literature and high quality methods to determine the cycle phase, namely hormone confirmation. If a study reported multiple effect sizes, we used the composite score method to aggregate these into a single effect size [41].

Speed and accuracy across the cycle

In our comprehensive review, we also include two different types of variables for each domain—that is, both speed and accuracy of responses across the cycle. Researchers have often used measures that contain both a timing and accuracy component. For example, the Stroop task can be measured in terms of latency of responding to stimuli or accuracy in naming stimuli. When performing such tasks, participants can make a tradeoff in how they respond—they can take longer to deliver more accurate responses or deliver faster responses but with increased errors [4244]. Researchers have long observed this tradeoff as an empirical regularity across a variety of domains [42,45]. Evidence suggests that speed and accuracy performance are based on accumulated information—faster responses are a product of less informed decisions whereas accuracy reflects a greater amount of information accrued [45,46]. As such, we attempt to observe general trends by analyzing response speed and accuracy scores separately.

Speed and accuracy performance depend on the type of task as well as instructions given to participants [44,47]. For example, instructions or incentives to prioritize speed or accuracy bias performance toward those goals [45]. In aggregating across multiple studies, we observed varying tasks and response formats, and due to this variability among protocols it is not possible to estimate a general speed and accuracy tradeoff function across the menstrual cycle. Nevertheless, we can still observe overall trends for providing quicker and/or more accurate responses across the cycle by separately analyzing response speed and accuracy measures.

We attempt to account for the potential effects of fatigue. In general, experimentally-induced mental and physical exertion can change speed and accuracy in dexterity tasks. Whereas mental exertion decreases both accuracy and speed [48,49], physical exertion only reduces accuracy [49]. This matters because fatigue can vary across the cycle. More than 50% of women report fatigue around the menstrual phase, even when taking oral contraceptives (OC) [50]. When mental and physical fatigue are measured separately, women report higher mental fatigue in the luteal compared to the follicular phase, while levels of physical fatigue did not fluctuate [51]. When measured with ergometers, women are most fatigued during the menstrual, followed by the follicular, then the luteal phase [52]. Such patterns suggest that with fatigue varying across the cycle speed and accuracy may vary as well.

Overview of study

We conducted a meta-analysis of studies in which cognitive performance was measured in multiple parts of the cycle. We include studies using both longitudinal and cross-sectional designs, as well as studies that used hormonal assays or other means of cycle phase determination. This allows the possibility to observe differences in results when using varying methodologies. We report results using the guidelines recommended by the Meta-analysis of Observational Studies in Epidemiology Group [MOOSE; 53] and, where possible, the American Psychological Association’s quantitative meta-analysis article reporting standards.

Method

Literature search strategy

We conducted a systematic review of electronic databases that could contain research about human behavior with respect to the menstrual cycle: PsycInfo, Pubmed, Social Science Research Network, Econlit, and the National Bureau of Economic Research. These databases contain behavioral research published in a journal article format, books, dissertations, and unpublished working papers. In each database, we used the following terms to retrieve documents: menstrual, menses, estrus, oestrus, progesterone, estrogen, oestrogen, luteal, follicular, and ovulation. Because we wanted to focus on the cycles of menstruating females, we set limits for databases that had this option. For Pubmed, we included articles relevant to human, female, published in English (due to resource constraints), and with participant populations aged from 6 to 64, and excluded studies that contained the terms: embryo, cancer, treatment, pregnancy, epidemiology, infection, contract, case study, anorexia, bulimia, trial, syndrome, inflammation, congenital, disorder, pathogenesis, cell, virus, pathways, secretion, morphology, substrate, immunology, implant, arthritis, and urinary. For PsycInfo, we included articles that were published in English, had female participants, and with participant populations aged from 6 to 64. We placed no lower bound limitations on published date of the study, and searched for records as recent as January 2024. In addition to papers identified through this search, we also added papers from prior attempts at systematic reviews [34,54]. No specialized software was used to conduct the literature search, but the citation management software Zotero [55] was used to manage bibliographic information (e.g., remove duplicate records). All studies analyzed were from published papers or available on a dissertation database. Fig 1 shows a flowchart of the study selection process.

Fig 1. Study Selection Flowchart.

Fig 1

Diagram of study selection process for the meta-analysis.

The first round of inclusion criteria involved examining the title and abstracts of the papers for mentions of cognitive performance across the menstrual cycle. We added to that list by conducting forward and backward citation searches of those articles using Google Scholar. We also requested unpublished papers and datasets on listservs for the American Psychological Association division for the Society for Experimental Psychology and Cognitive Science and the Society of Menstrual Cycle Research in February 2022. These inquiries did not result in identifying additional manuscripts or data that could be included in the analyses.

The full texts of the papers remaining in the candidate pool were subject to a second set of criteria. Papers were included if they provided the number of women measured for a cognitive ability within menstrual phases defined in terms of specific days of the cycle. We included measures of cognitive ability that were guided by prior research [40,56], in particular the domains of attention, creativity, executive function, intelligence, memory, motor function, spatial ability, and verbal ability. The full list of measures within each category appears in Table 1. Papers that did not define the menstrual cycle in terms of specific cycle date ranges and case studies were excluded because they contained insufficient information to compute effect sizes [e.g., effect size mentioned in text but could not determine the direction of effect; [57]]. In addition, we excluded samples if they measured women only at a single point in the cycle. The first author, who holds an M.A. and Ph.D. in Organizational Behavior, conducted the literature search, and extracted all data from the articles and coded all variables.

Table 1. List of measures.

Domain Measures
Attention 2 and 7 test, attention subset Repeatable Battery for the Assessment of Neuropsychological Status, attention direction task, Brief Test of Attention, color trails I, concept formation, Continuous Performance Test, d2 test of attention, decision speed subset Woodcock Johnson III, digit span task, digit span (unspecified), digit span forwards, digit symbol, face decision task, face discrimination, figural comparison, finding As task, gestalt task, global-local task, inhibition of return task, letter detection task, lexical decision task, matching familiar figures test, number cancellation, number comparison, Paced Auditory Serial Addition Test, perceptual speed task, proof-reading test, reaction time task, serial choice task, Stroop task, target identification, trail making test A, visuospatial attention task
Creativity Alternative uses task, consequences task, instances task, pattern meanings task, planning task, plot titles task, possible jobs task, similarity task, synonyms task, Torrance Tests of Creative Thinking
Executive function Abstraction subset of Shipley Institute of Living Scale, arithmetical thinking, block design, color figure maze, color trails II, concept formation, Controlled Oral Word Association Test, critical thinking, deductive reasoning, digit span, backwards, figure classification, ideas generation, inference test, letter series test, mathematic test, object assembly subset Wechsler scale, phonemic fluency, rhyme generation, synonym generation, Tower of London, tracing task (complex), trail making test B, verbal fluency, word generation
Intelligence Cattell Fluid Intelligence Test 20, General information subset Woodcock Johnson III, General Mental Ability Test, Multiple Choice Vocabulary test, Raven’s progressive matrices, Repeatable Battery for the Assessment of Neuropsychological Status overall score, vocabulary task
Memory 10/36 Visuospatial learning test, associative learning, Benton Visual Retention Test, Brief Visuospatial Memory Test Revised, California Verbal Learning Test, category exemplar generation, digit span subset Wechsler scale, digit span (forward and backward), figure memory, fragmented object identification, letter elimination, logical memory, N-back, paragraph recall, pattern recognition, picture number, picture recognition, recall task, Rey auditory verbal learning test, search test, short delay subset Wechsler scale, spatial array task, spatial recognition, spatial working memory, story recall, verbal working memory, visual memory test, visual reproduction, memory subset Wechsler scale
Motor function Arm steadiness, extrapersonal motor, finger tapping, grooved pegboard, line-tracing, manual sequence box, mirror tracing, Purdue pegboard test, pursuit rotor, video game score
Spatial ability Card rotations, cube comparisons, embedded figures, flags test, form board, hidden figures, hidden patterns, line orientation, mental rotation, mirror pictures, mirror tracing, navigation task, nearer point, paper folding, rod-and-Frame, size-estimation, space relations, space subset Primary Mental Abilities, spatial ability subset Woodcock Johnson III, surface development, visual matching subset Woodcock Johnson III, visuospatial subset Repeatable Battery for the Assessment of Neuropsychological Status, visuospatial composite, water level
Verbal ability Anagrams, articulation, comprehension subset Woodcock Johnson III, language subset of the Repeatable Battery for the Assessment of Neuropsychological Status, object naming, verbal comprehension, verbal subset of Shipley Institute of Living Scale

Data coding and interrater reliability

Date of data extraction was not retained since specialized software for meta-analysis was not used. The second author served as a second coder, independently examining 15% of studies (i.e., 15) selected at random. The second coder recorded the means, standard deviations, and N associated with each dependent variable, as well as study characteristics (design, country, age mean, and age SD). There was 96% agreement between the two raters on these records. Disagreements in coded values were discussed until fully resolved.

Definition of menstrual cycle

Apart from a nearly universal agreement across the studies sampled that a menstrual cycle is typically 28 days long, there was no consistent agreement on the number and length of phases across studies. Thus, we relied on a precedent set by [58] in their meta-analysis of pain perception across the menstrual cycle. They divided a nominal 28 day cycle into five phases: Phase 1 – menstrual (days 1-5), Phase 2 – follicular (days 6-11), Phase 3 – periovulatory, days 12-16, Phase 4 – luteal (days 17-23), Phase 5 – premenstrual (days 24-28). This division of the cycle has been used in subsequent meta-analyses [38,59]. Studies that did not use this definition to define cycle phases required further classification. If a phase definition used in the paper differed from the one above, we assigned it to the phase where the majority of its days aligned. For example, if a study defined the follicular phase as days 5-12, we categorized it under Phase 2 (the follicular phase). If a phase definition evenly straddled our defined range (e.g., luteal phase defined as days 14-19), we excluded it from analyses. To test the robustness of the results, we analyze the data using additional criteria, which we describe in a later section. Most studies did not report results by day of cycle, and so an analysis based on days of cycle as predictor was not possible.

Computation of effect sizes

We chose Hedges’ g as the effect size for analysis, given it is an optimal estimator for small sample sizes, which were common in the studies included. We attempted to include as many effect sizes as possible by requesting data or summary statistics from the original authors when results were verbally reported as non-significant, or when the direction of the difference could not be obtained. We obtained data for two cases where authors responded to requests (response rate =  13%). Where data or summary statistics could not be obtained, we imputed an effect size of zero for studies that reported a non-significant difference or excluded the study if we could not determine the direction of the effect size. All other studies were retained in the analyses.

Computing Hedges’ g with repeated measures requires taking into account the test-retest correlation because ignoring reliability can result in bias [60]. Because many studies did not report test-retest reliabilities, we contacted authors of papers for the statistic or raw data and authors provided data in four cases (response rate =  9%). In total, we were able to obtain reliability for 11 studies. In the absence of primary data, we identified a meta-analysis of the test-retest reliability of cognitive measures [61] and computed the average reliability, which was.73. Where primary data were not available, we used this imputed value.

Our data contained both cross-sectional and repeated measures designs, necessitating conversion of effect sizes. Effect sizes computed for repeated measures designs and independent groups designs are not directly comparable because different degrees of freedom are used to calculate each [62,63]. Thus, we converted effect sizes from cross-sectional studies to the repeated measures metric of Hedges’ g, imputing the average reliability observed by Calamia and colleagues [61].

Because we were interested in overall cognitive performance, we aggregated data across groups when data were reported separately for groups that had no treatment or clinical basis, such as group differences in attitudes or personality (e.g., introverts vs. extroverts; [64]), and likewise for performance differentiated by laterality (e.g., left vs. right visual field in lexical decision task; [65]). Doing so limited highly correlated effect sizes across samples. Samples served as the unit of analysis [66]. All data required to replicate the study are presented in S1 Table. We did not attempt to impute any missing effect size data. All studies included in the analyses were eligible to be included.

Analysis strategy

We conducted a bare-bones meta-analysis using the psychmeta package (version 2.7.0) with the R statistical software language. We conducted a series of analyses comparing each phase against others, as in prior meta-analyses that examined differences across phases for effect sizes based on continuous measures [e.g., meta-analysis of pain perception across the menstrual cycle; 58]. In some cases, papers reported multiple effect sizes for the same domain of cognitive performance [e.g., reporting multiple measures of spatial ability as in 67], which creates issues of statistical non-independence. Although effect sizes could be averaged within study, the composite variable approach is favored since it generates unbiased variance estimates and an effect size of greater validity [41]. Conceptually, composite variables are analogous to deriving an average through factor analyses of multiple items vs. computing a simple average [41].

We also corrected for psychometric artifacts due to measurement errors [41,68]. Because the key test we aimed to perform was differences in performance across time, correcting for test-retest reliability was necessary to avoid issues of bias in effect sizes. As above, where test-retest reliability was not available from primary data, we imputed the meta-analytic reliability figure for cognitive measures [61]. We also excluded three extreme outliers (i.e., g>  | 5|) from analyses.

To gain deeper insight into the nature of potential differences across the cycle, we also examined separately measures of speed (e.g., response latency, time to test completion) and accuracy (e.g., percentage correct) within each domain of cognitive performance. Some papers only reported composite effect sizes of multiple measures where the unit of measurement was not specified. We included these in overall analysis while excluding them from the speed and accuracy subset analyses.

Assessment of heterogeneity and study quality

Heterogeneity was assessed across all analyses using the Q test for residual heterogeneity.

We conducted additional analyses that included only naturally cycling participants and excluded participants receiving treatments or interventions that could influence performance [e.g., participants receiving peptide injections; 69]. When examining this subset, we further excluded women with clinical diagnoses and anovulatory women. To serve as a point of comparison, we complemented these analyses with analyses of oral contraceptive (OC) users, where studies included such comparison groups. Although women on OC do not experience ovulation and therefore not a conventional menstrual cycle, they still serve as a useful comparison group against which the potential effects of hormonal shifts can be observed.

We also conducted tests to examine the robustness of results. A previous review indicated that the method of determining menstrual cycle phase was a key indication of study quality, with hormonal assays representing the highest quality [70]. Thus, we tested for the robustness of the main conclusions by comparing the pattern of results against the subset of studies that assessed naturally cycling women whose cycles were confirmed using hormonal measures such as blood assays or luteinizing hormone tests. Other methods, such as counting days from menstruation and changes in basal body temperature were not considered in robustness tests because they are not reliable indicators of physiological changes [32]. For example, no counting method had a higher than 30% probability of determining ovulation, compared to luteinizing hormone measures [71]. In addition, we attempted to account for the varying definitions of menstrual cycles across studies. We conducted subset analyses including studies that included phase definitions that have an 80% overlap with our definition of the cycle among naturally cycling women. For example, Broverman and colleagues [72] measured participants on day 20 ±  2 days, meaning all of the days specified overlapped with our definition of the luteal phase. In contrast, Arushanyan and Borovkova [64] measured women on days 1-8, representing a 62.5% overlap with our definition of menstrual phase. While 80% is an arbitrary threshold, it provides insight into how the results might differ if cycle definitions more closely conformed to precedent definitions.

As additional analyses, we examined the cycle with respect to a three-phase cycle, defined as the menstrual phase, the ovulation phase, and an aggregate of the other phases. While we recognize that the five phase definition of the cycle is the most appropriate way to define the cycle, a three-phase definition can offer a conceptual robustness check with respect to the menstrual and ovulatory phases. This is because the menstrual phase is readily detectable via self-report and the ovulation phase is detectable through multiple physiological tests (LH surge, body temperature shift). Contrasting these phases to the remainder of phases that may be less detectable provides an additional opportunity to examine these phases with greater power. We note that this definition of the cycle for these additional analyses precludes the possibility of comparing the follicular, luteal, and premenstrual phases.

Open practices statement

All code used for this study are available from the authors on request. No data were omitted from analyses. Data were analyzed using the R statistical programming language, using

Results

Given the large number of results, we provide a simplified qualitative summary of them in Table 2. Key results are shown in Table 3, with detailed statistics in S2–S9 Tables.

Table 2. Simplified Outline of Results.

Cognition domain Result
Attention No significant differences across the cycle
Creativity No significant differences across the cycle
Executive function No significant differences across the cycle
Intelligence No significant differences across the cycle
Memory Differences across the cycle in overall sample but none robust to multiple comparison correction or use of rigorous methods
Motor function No significant differences across the cycle
Spatial ability Differences across the cycle in overall sample but none robust to multiple comparison correction or use of rigorous methods
Verbal ability Differences across the cycle in overall sample but none robust to multiple comparison correction or use of rigorous methods

Table 3. Summary of Meta-analytic Results for Entire Sample and Hormone Confirmation Studies.

Five phase comparisons Three phase comparisons
P1 vs P2 P1 vs P3 P1 vs P4 P1 vs P5 P2 vs P3 P2 vs P4 P2 vs P5 P3 vs P4 P3 vs P5 P4 vs P5 P1 vs. P3 P1 vs. rest P3 vs. rest
Attention
Entire sample
Speed and accuracy -0.279 -0.024 -0.027 -0.038 0.084 0.282 0.036 -0.085 0.063 0.315 -0.024 -0.083 0.046
Speed -0.362 -0.135 -0.032 -0.072 0.061 0.332 0.042 -0.063 0.261 0.318 -0.135 -0.035 0.121
Accuracy -0.066 0.122 -0.069 -0.217 0.007 0.031 -0.098 -0.230 -0.180 -0.246 0.122 -0.144 -0.177
Hormone confirmation of cycle phase
Speed and accuracy -0.205 -0.056 0.196 -0.245 -0.064 0.183 -0.082 0.008 0.118 -0.026 -0.056 0.120 0.010
Speed -0.470 -0.216 0.080 -0.245 -0.074 0.190 -0.030 0.073 0.264 -0.026 -0.216 0.018 0.055
Accuracy -0.050 0.120 0.189 -0.046 0.119 -0.114 -0.201 0.120 0.111 -0.102
Creativity
Entire sample
Speed and accuracy -0.817 0.385 0.089 1.528 0.155 -1.175 0.569 0.679
Speed
Accuracy -0.817 0.385 0.089 1.528 0.155 -1.175 0.569 0.679
Hormone confirmation of cycle phase
Speed and accuracy -1.175 0.385 1.528 -1.175 0.569 2.071
Speed
Accuracy -1.175 0.385 1.528 -1.175 0.569 2.071
Executive function
Entire sample
Speed and accuracy 0.062 -0.022 -0.005 -0.023 -0.447 0.079 -0.070 -0.056 -0.013 -0.017 -0.022 0.041 0.057
Speed -0.046 0.238 0.172
Accuracy 0.088 -0.041 -0.028 -0.023 -0.558 0.078 -0.104 -0.101 -0.013 -0.017 -0.041 0.046 0.057
Hormone confirmation of cycle phase
Speed and accuracy -0.082 0.140 0.070 -0.207 0.476 -0.082 0.159 0.217
Speed 0.330 -0.134
Accuracy -0.058 0.161 0.057 0.476 -0.058 0.180 0.217
Intelligence
Entire sample
Speed and accuracy 0.396 -0.330 0.192 -0.072 0.396 -0.372 -0.143
Speed
Accuracy 0.396 -0.330 0.192 -0.072 0.396 -0.372 -0.143
Hormone confirmation of cycle phase
Speed and accuracy -0.132 -0.162 -0.072 -0.132 -0.211 -0.143
Speed
Accuracy -0.132 -0.162 -0.072 -0.132 -0.211 -0.143
Memory
Entire sample
Speed and accuracy -0.045 0.045 -0.004 -0.065 -0.023 -0.057 0.167 -0.143 *  0.045 0.001 0.091
Speed -0.056 -0.070 0.979 -0.099 0.691 -0.070 0.331 1.108
Accuracy -0.040 0.054 -0.084 -0.087 -0.021 -0.106 0.057 -0.175 0.054 -0.066 -0.022
Hormone confirmation of cycle phase
Speed and accuracy -0.054 -0.168 -0.109 0.059 -0.128 -0.441 0.492 -0.168 -0.129 0.482
Speed -0.056 -0.060 0.979 1.465 -0.060 0.365 1.448
Accuracy -0.045 -0.142 -0.246 0.032 -0.129 -0.441 -0.014 -0.142 -0.225 -0.022
Motor function
Entire sample
Speed and accuracy 0.078 0.233 -0.220 0.000 -0.099 0.129 0.233 -0.140 0.000
Speed -0.253 0.050 0.207 -0.217
Accuracy 0.082 0.000 -0.116 0.000 -0.083 0.000 -0.077 0.000
Hormone confirmation of cycle phase
Speed and accuracy 0.247 -0.286 -0.212 -0.244
Speed -0.510 -0.093 -0.426
Accuracy 0.299 0.163 0.115 0.057
Spatial ability
Entire sample
Speed and accuracy -0.102 0.098 0.045 -0.125 -0.141 *  -0.179 *  -0.028 -0.017 -0.140 0.108 0.098 0.038 -0.021
Speed -0.135 -0.116 -0.139 -0.227 -0.261 -0.180 0.200 -0.116 -0.131 0.255
Accuracy -0.119 0.110 0.072 -0.099 -0.141 -0.122 0.068 -0.014 -0.140 0.115 0.110 0.065 -0.020
Hormone confirmation of cycle phase
Speed and accuracy -0.068 0.052 0.092 -0.139 -0.297 *  0.088 0.041 0.052 0.122 0.182
Speed -0.236 -0.174 -0.348 0.273 -0.236 -0.157 0.307
Accuracy 0.022 0.065 0.125 -0.139 -0.162 0.099 0.041 0.065 0.161 *  0.186
Verbal ability
Entire sample
Speed and accuracy 0.314 0.233 -0.125 0.161 -0.112 0.892 *  -0.052 -0.999 *  0.314 0.152 0.325
Speed 0.170 0.161 0.185
Accuracy 0.097 0.103 -0.131 0.895 -0.078 -1.082 0.097 0.066 0.232
Hormone confirmation of cycle phase
Speed and accuracy
Speed
Accuracy

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase. Asterisks (*) indicate coefficients with confidence intervals that do not include zero. This table displays only average effect sizes for two subsets of data. Results for additional subset analyses (e.g., naturally cycling subset) and additional statistics, including including number of studies, sample size, SE, confidence intervals, credible intervals, and heterogeneity statistics are shown in S2S9 Tables.

Attention

When examining all samples combined, there were no significant differences in performance in attention tasks (Table 3). When examining the five-phase definition of the cycle, there were also no significant differences in speed or accuracy scores separately. Similar patterns appeared when only naturally cycling women were examined. Only three comparisons involving OC users could be tested, which were all non-significant (S2 Table). Robustness tests involving the subset of studies that overlap 80% or greater in phase definitions and studies using hormone confirmation revealed no significant differences. Heterogeneity tests were often significant when examining the full sample, but almost all were non-significant in the two robustness tests, which suggests that much of the heterogeneity can be explained by phase determination methods and disappears when examining only those studies with more stringent measures.

When examining analyses that used the three-phase definition of the cycle none of the comparisons were significant.

This is a domain of research for which there was a relatively high number of published papers (max k =  28).

Creativity

When examining all samples combined, there were no differences in levels of creativity across the menstrual cycle (Table 3), when operationalizing the cycle into five phases. There were no measures of creativity based on speeded reactions, meaning that there was no opportunity to examine it in this domain. Examining only naturally cycling women also revealed no significant differences across the cycle (S3 Table). Only one study measured creativity of OC users across the cycle so we did not attempt analyses. Robustness tests with studies that have 80% overlapping phase definition and hormone confirmation studies did not reveal significant differences. Throughout, heterogeneity in the ovulatory vs. luteal phases remained unexplained.

Examining studies using the three-phase definition of the cycle also revealed no significant differences across the cycle.

The number of studies in this domain was low (max k =  4), suggesting much scope for additional research.

Executive function

Executive function enables people to engage purposefully and independently in goal directed behavior [56]. When examining all samples combined and operationalizing the cycle into five phases, there were no significant differences in executive function across the menstrual cycle (Table 3). There were no differences in aggregate scores, nor when speed and accuracy scores were examined separately. This pattern was replicated among naturally cycling women and OC users (S4 Table). Robustness tests with studies that have 80% overlapping phase definitions and hormone measures for cycle determination also showed non-significant differences. Although some of the heterogeneity tests were significant when examining the full sample, the vast majority were non-significant in the robustness tests, which suggests methodological reasons for observed heterogeneity.

Examining studies using the three-phase definition of the cycle revealed no significant differences across the cycle.

The number of studies in this domain was relatively high (max k =  21).

Intelligence

When examining all samples combined, there were no significant differences in apparent intelligence across the menstrual cycle (Table 3), when operationalizing the cycle into five phases. There were no measures of intelligence based on speeded reactions in this domain. Examining only naturally cycling women also revealed no significant differences (S5 Table). No studies examined the intelligence of OC users across the cycle. Robustness tests with studies that have 80% overlapping phase definition and hormone confirmation studies also revealed non-significant differences. Although some of the heterogeneity tests were significant when examining the full sample, none were significant when examining hormone confirmation studies, which suggests that methodology was the reason for heterogeneity in the full pool of studies.

Examining studies using the three-phase definition of the cycle revealed no significant differences across the cycle.

As with creativity, the number of studies in this domain was low (max k =  6), suggesting much scope for additional research.

Memory

When examining all samples combined, there were some significant differences, but these were not robust. Aggregate memory scores appeared better in the premenstrual vs. ovulation phase (Table 3), when operationalizing the cycle into five phases. However, when a Bonferroni correction was applied for multiple comparisons against the number of comparisons performed for the five-phase definition (i.e., 517 comparisons), the difference was no longer significant. Moreover, this difference was non-significant when accuracy scores were examined on their own. A similar pattern emerged amongst the subset of naturally cycling women (S6 Table). Based on the data available only one comparison was possible to examine for those who used OCs, and it revealed no significant difference between the menstrual and ovulatory phases. Robustness tests also revealed no significant differences across phases for either the 80% overlap or hormone confirmation studies. Across analyses, heterogeneity remained significant for menstrual vs. luteal, and follicular vs. premenstrual comparisons, which suggests that factors other than cycle determination methods may be involved in accounting for the variability of those effects.

Examining studies using the three-phase definition of the cycle revealed no significant differences across the cycle.

This is a domain of research for which there was a moderate number of published papers (max k =  16).

Motor function

When examining all samples combined, there were no significant differences in motor function across the menstrual cycle (Table 3). Neither the overall score nor the speed and accuracy scores revealed significant differences, when operationalizing the cycle into five phases. Naturally cycling women did not exhibit differences and there were insufficient data on OC users to conduct analyses (S7 Table). Both the 80% overlap and hormone confirmation robustness tests resulted in no significant differences observed. Across analyses, none of the heterogeneity tests were significant.

Examining studies using the three-phase definition of the cycle revealed no significant differences across the cycle.

This is a domain of research for which there was a moderate number of published papers (max k =  9).

Spatial ability

Some differences in spatial performance were observed with respect to the follicular phase. When examining all samples combined, there was an accuracy advantage in the ovulatory vs. follicular phase (Table 3), when operationalizing the cycle into five phases. The same comparison was significant among the naturally cycling women (S8 Table). When Bonferroni corrections were applied, the overall sample difference was still significant. However, this comparison was non-significant in studies that measured hormones to confirm cycle differences. As such, this difference does not appear robust.

There was also a non-robust advantage for the aggregate measure of spatial performance in the luteal vs. follicular phase. This comparison was significant among naturally cycling women, and in studies that used cycle definitions that overlap 80% with ours. It was also significantly different in studies that used hormone tests to confirm phases. However, the difference was not robust to Bonferroni correction. Moreover, while the aggregate measure of spatial performance showed a robust difference, speed and accuracy measures did not independently demonstrate significance.

Tests using the three-phase definition showed some differences. Although the menstrual phase was associated with slower responses compared to the rest of the phases when comparing the overall and naturally cycling subsets, this difference was non-significant in 80% overlap and hormone confirmation subsets. And although we observed a difference between the menstrual phase and remainder of phases in the 80% overlap and hormone confirmation subsets, these differences were not robust to Bonferroni correction.

Some tests of heterogeneity were significant in the overall and naturally cycling subsample, but they were non-significant in the 80% overlap and hormone confirmation subsets. This suggests that there was heterogeneity in observed effect sizes for methodological reasons. The number of studies in this domain was relatively high (max k =  35).

Verbal ability

We observed non-robust differences across the cycle. When examining all samples combined, participants had higher aggregate verbal performance in the ovulatory vs. luteal phase (Table 3). However, this was not observed in the naturally cycling subset (S9 Table), nor was the difference robust to Bonferroni correction. No data was available to examine this comparison amongst OC users, and no studies that shared 80% overlap in phase definition examined the phases. No studies in this domain examined phase differences using hormone confirmation methods.

Similarly, while there was an advantage in the premenstrual vs luteal phase based on the overall sample, which survived Bonferroni correction but evidence using more robust methods did not corroborate this pattern. The difference was non-significant among naturally cycling women, and among studies that shared 80% overlap in phase definition. As above, no studies used hormone confirmation methods in this domain.

Results using the three-phase definition revealed a non-robust difference. In the overall sample, women were more accurate in the ovulatory phase compared to the remainder of phases, but this difference could not be observed in the naturally cycling or any other subset due to the lack of available data.

Heterogeneity for the menstrual vs. luteal comparison remained significant throughout analyses, which suggests that additional factors may be involved in accounting for the variability of those effect sizes. This is a domain of research for which there was a low number of published papers (max k =  7).

Examination of publication and small-study bias

We examined evidence of publication bias by examining funnel plots that placed each effect size against the standard error (Fig 2). Although outliers were present in some cases, we did not observe patterns of asymmetries in effect sizes that indicated publication bias. Egger’s test for plot asymmetry was non-significant (b =  0.025, t =  -1.250, df =  1163, p =  0.212), indicating an absence of small-study or publication bias. All articles examined in this meta-analysis are listed in S10 Table. We did not assess individual studies for risk of bias, as it was not a part of the study design.

Fig 2. Overall funnel plot.

Fig 2

Funnel plot of studies included in the meta-analysis.

Power analysis

We conducted a power analysis using the metapower package (version 0.2.2) with the R statistical software language [73]. The package was developed following the power analysis approach in meta-analyses suggested by past research [74,75]. We used an estimated small-to-medium effect size of the comparisons across phases of the menstrual cycle (Hedge’s g = .35) and the average participant sample size of the studies in our meta-analysis (N =  39) to determine the number of studies needed to detect the effects [76,77]. The analysis suggests that at least seven studies are required to achieve 80% power at an α of .05. The results caution in interpreting results for estimates involving fewer than 273 participants.

Discussion

We find little consistent evidence that women’s cognitive ability changes across the menstrual cycle when examining numerous domains of cognitive performance. Across 517 comparisons when using the five-phase definition, no difference we observed was robust to both Bonferroni corrections and supported in work that used robust methods. Similarly, across 213 comparisons when using the three-phase definition, again none were robust to Bonferroni corrections nor the use of robust methods. The lack of robust differences across a large number of comparisons suggests that there is little if any variability across the menstrual cycle in objectively scored cognitive tasks.

This lack of findings is somewhat surprising given the numerous documented physiological changes that occur across the cycle. Levels of estrogen, progesterone, and luteinizing hormone fluctuate in a well-understood manner, and receptors for estrogen in particular are present in many parts of the body, including the central nervous system and the brain [27]. Moreover, both brain structure and functional activation patterns change across the cycle [17,18,23,24], which suggests fluctuations in ability. However, the lack of evidence to support this claim suggests that the changes in brain structure and activation patterns are either small enough in magnitude that they do not have measurable influence on performance, or that women compensate for such changes through mechanisms not yet understood. Physiology does not appear to be destiny with respect to cognitive ability. Another possibility is that individual differences in responsiveness to changes in the brain are larger in magnitude than the changes themselves. This pattern was previously observed in menstrual cycle research—although levels of endogenous hormones did not differ across the cycle between those with and without premenstrual syndrome [37], individual response to hormones appeared to be responsible for premenstrual symptoms.

The results are in line with the conclusions of researchers who argued that cognitive performance does not change throughout the cycle [10,2832,34]. Observing the small and inconsistent differences led them to conclude there was no substantive difference. Modern studies that incorporated functional brain imaging alongside cognitive measures also showed no cycle fluctuations [23,24,35,36].

This meta-analysis also examined to what extent women provide faster or more accurate responses across the cycle. Existing research on mental and physical fatigue suggested the possibility of speed and accuracy differences. However, despite the potential for greater mental and physical fatigue, particularly during the premenstrual and menstrual phases [1416], we did not observe evidence consistent with this.

Evaluating conflicting claims about women’s cognitive performance is limited by methodological challenges with menstrual cycle research. Small sample sizes and inconsistent operationalization of cycle phases make data difficult to aggregate. To account for these challenges, we conducted multiple robustness tests that evaluated evidence by examining effects among naturally cycling women, against stricter definitions of cycle phases and through hormone confirmation of phases. Doing so, only two comparisons were significant and even those resulted from a large number of unfocused comparisons and should be evaluated in that light.

In discussing these non-significant results we note that the absence of evidence for an effect is not evidence that the effect is absent. Using frequentist methods as we have done in this paper, it is not possible to conclude that a non-significant result is due to a true lack of differences between cycle phases. Some of the non-significance could be attributed to the lack of power due to small sample size, as we mention above in conducting the power analyses. A non-significant result could be due to methodological differences across studies, such as varying operationalizations of constructs (e.g., measuring attention through accuracy on the Stroop vs. color trail tasks). However we note that one prior meta-analysis that examined a narrow set of cognitions using similar methods (mental rotation tasks) also did not find significant cycle differences [34]. Another possibility is that subgroups of women exist, who have varying levels of performance across the cycle. Aggregating across distinct subgroups may mask between group differences. A different possibility is that most of the studies were conducted on women in developed countries with a high standard of living. Such contexts should afford women with greater access to health education, hygiene products, and good nutrition. Such factors may moderate the effects of hormonal shifts. Prior evidence suggests another possibility, namely that individual differences in responsiveness to cycle shifts could be larger in magnitude compared to cycle shifts themselves [37]. Thus, caution is warranted in interpreting these non-significant results and further research is warranted.

The results we obtained have implications for policy and social justice. Women appear to think no less effectively across their menstrual cycle, even if subjective experiences can be negative in certain phases. We argue there is no scientific basis to support societal norms to eliminate or reduce women’s freedoms or responsibilities through legal or organizational policy. Similarly, we argue there is no basis for attitudes, practices, and commentary that question women’s cognitive performance across the cycle. Such questions leveled at candidate Hillary Rodham Clinton have undoubtedly been repeated to countless other women.

Limitations and future directions

We find no systematic evidence of differences in cognitive performance across the menstrual cycle in the existing literature to date. That said, one can never prove a null hypothesis, but merely to establish that an effect would need to be very small if it does exist based on the methods used in existing work. There remains much room to advance knowledge in this line of research, and different types of investigations could yield different results than those reviewed here. Below we outline several areas for expanding the current body of evidence.

First, we note that some areas of research have attracted relatively little research attention and would benefit from more. For example, few studies examine verbal ability across the cycle, and none while confirming cycle phase with hormone measures. Research in the rows of our tables with missing data would serve to solidify our understanding of menstrual cycle changes in cognitive performance. We hope that this paper not only reviews what the field knows but also identifies specific areas to move the field forward.

Second, we call for more consistent operationalization of the menstrual cycle in future research. A technical difficulty we encountered was the substantial variance in how the cycle was defined in terms of a standardized 28-day cycle. This poses a challenge to accumulating knowledge. We repeat the call from prior research to standardize cycle definitions to aid future understanding [33,34,38,39,59]. In concert, we encourage the use of hormone based measures to confirm cycle phases, as counting methods can be unreliable indicators [32,71].

Third, we note the limited range of women studied in this line of research, namely eumenorrheic women in wealthy industrialized countries with relatively greater access to menstrual products and science-based education about the menstrual cycle as well as less societal and cultural stigma attached to menstruation. As we reviewed in the introduction, there are external factors that could impact women’s cognition regardless of any biological differences in functioning. They involve societal, cultural, and religious beliefs that treat menstruation as a taboo [6,7,12,78]. These attitudes have been used to devalue women [79]. For example, women were judged to be of lower competence and were liked less when they accidentally dropped a tampon vs. a hair clip, suggesting cues about menstruation elicit a denigrating response [80]. This effect was similar for both women and men evaluators, suggesting that systemic attitudes can be internalized. Beyond attitudes, such attitudes toward menstruation can translate into limiting women’s access to locations where they are required to perform effectively, resulting in a lack of opportunity to demonstrate competence. These attitudes can translate to physical sanctioning, such as when menstruating women are explicitly prohibited from social activities [7]. Similarly, women of low socioeconomic status can find it difficult to access sanitary products or experience stigma when trying to access them [6]. Those products can facilitate participation, and a lack of access can lead to functional impairment. Both negative attitudes and societal exclusion can represent a persistent and substantial source of stress. Stress is known to impair cognitive function [81], so women’s ability to perform cognitive tasks may be reduced by external constraints. Additional research that systematically explores external factors is necessary to understand better how to address this issue. We note that there is insufficient statistical power in our meta-analysis to explore systematically either this question or other confounding factors (e.g., level of education)—to detect a moderate effect size (.30) with 80% power in an individual study, a sample size of 84 is required, which far exceeds the average sample size of approximately 39 women.

Accumulating studies that feature larger sample sizes in diverse contexts will be necessary. Women were not included in the original studies reviewed here if they have irregular menstrual cycles or mental health diagnoses, as they are routinely excluded through selection criteria in the original studies. Better understanding of their cognitive functioning will lead to a fuller account of women’s psychology overall.

Fourth, the focus of our analyses was overall cognitive functioning within a domain, and there are many subdomains with specific measures within domains, for example as conducted by Sundström Poromaa and Gingnell [34]. As such, we do not rule out the possibility that specific abilities could show cycle fluctuations even when the larger domains do not.

Fifth, although interrater reliability was high for a limited number of articles examined by two coders, the full set of articles was not coded by multiple authors. Multiple raters for each paper could increase the accuracy of the coded data.

Sixth, we could not isolate the effect of using different types of oral contraceptives (OC). Although twelve studies recruited women who use OCs, there was insufficient information provided to analyze specific types. Studies either did not report the type of OC used or reported that women used varying types of OCs. Only one study reported separate results by OC type. Investigating the association between oral contraception and cognition remains an avenue for future research.

Seventh, although we examined fluctuations in cognitive performance, we did not examine potential mechanisms that could underlie cycle fluctuations. Thus, we opted to exclude search terms such as ‘morphology’ in our literature search and focused on outcomes, namely measurement of performance. Future research should investigate potential mechanisms that link the cycle and cognition, to achieve greater theoretical understanding of this topic.

Finally, some of our conclusions were based on a small number of samples and/or sample size. Although our conclusions can only be based on what is published, as with any meta-analysis, smaller observations mean results are potentially affected by lack of statistical power. More research in those domains will help solidify understanding of cognitive performance in specific parts of the cycle. Likewise, additional data would be particularly worthwhile with diverse samples in terms of such factors as age, experience of pregnancy, proximity to menarche and/or perimenopause to help understand their potential influence on the association between the menstrual cycle and cognitive functioning.

Conclusion

The topic of women’s cognition and the menstrual cycle is important for a number of reasons. Studying it can enhance descriptive understanding of the cognitive functioning of half of the world’s population, dispel myths, and lead to better education about women’s issues. However, this stream of literature features multiple long-standing limitations. Sample sizes are typically small [27,34], which limits generalizability of any one study. Furthermore, studies typically assess a single aspect of cognition, which limits taking a holistic perspective on the relationship between the constructs.

By conducting the most comprehensive quantitative review of the literature to date across multiple domains of cognition, we address this limitation. We observe no systematic evidence of menstrual cycle shifts in cognitive performance. This contrasts with subjective and cultural expectations, and so it is noteworthy that while using measures that have objective correct vs. incorrect responses, women show no deficits or improvements in effectiveness across the cycle. This result has implications for addressing misconceptions and myths as well as addressing discriminatory practices, as we found no scientific basis for doubting women’s ability to think because of their menstrual cycle.

Supporting information

S1 Table. List of studies, measures, and effect sizes.

AO =  anovulatory, NC =  naturally cycling, OC =  oral contraceptives, BBT =  basal body temperature, L =  longitudinal, C =  cross-sectional, RBANS =  Repeatable Battery for the Assessment of Neuropsychological Status, WMS =  Wechsler memory scale, CVLT =  California verbal learning test, BVMT-R =  Brief Visuospatial Memory Test Revised, COWAT =  Controlled Oral Word Association Test, WAIS =  Wechsler Adult Intelligence Scale, WAIS-R =  Wechsler Adult Intelligence Scale-Revised, TTCT =  Torrance Tests of Creative Thinking, WJ III =  Woodcock-Johnson III Tests of Cognitive Abilities. aData obtained through correspondence, 7 Mar 2022. bData obtained through correspondence, 7 Mar 2022. cData obtained through correspondence, 17 May 2024. dData obtained through correspondence, 29 Jan 2022. eData obtained through correspondence, 18 Feb 2022.

(XLSX)

pone.0318576.s001.xlsx (92.5KB, xlsx)
S2 Table. Meta-analyses of attention measures.

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

(XLSX)

pone.0318576.s002.xlsx (26.8KB, xlsx)
S3 Table. Meta-analyses of creativity measures.

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

(XLSX)

pone.0318576.s003.xlsx (21.9KB, xlsx)
S4 Table. Meta-analyses of executive function measures.

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

(XLSX)

pone.0318576.s004.xlsx (25.8KB, xlsx)
S5 Table. Meta-analyses of intelligence measures.

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

(XLSX)

pone.0318576.s005.xlsx (21.3KB, xlsx)
S6 Table. Meta-analyses of memory measures.

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

(XLSX)

pone.0318576.s006.xlsx (24.9KB, xlsx)
S7 Table. Meta-analyses of motor function Measures.

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

(XLSX)

pone.0318576.s007.xlsx (22.9KB, xlsx)
S8 Table. Meta-analyses of spatial ability measures.

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

(XLSX)

pone.0318576.s008.xlsx (26.7KB, xlsx)
S9 Table. Meta-analyses of verbal ability measures.

All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

(XLSX)

pone.0318576.s009.xlsx (22.5KB, xlsx)
S10 Table. List of articles analysed in the meta-analysis.

(XLSX)

pone.0318576.s010.xlsx (20.2KB, xlsx)
S11 Table. List of articles excluded from the meta-analysis.

(XLSX)

pone.0318576.s011.xlsx (14.7KB, xlsx)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Golub S. Preface. Women & Health. 1983;8(2–3):xi–XIII. doi: 10.1300/j013v08n02_a [DOI] [PubMed] [Google Scholar]
  • 2.Blakeslee S. Female sex hormone is tied to ability to perform tasks. The New York Times. 18 Nov 1988. [cited 2022 Mar 1]. Available from: https://www.nytimes.com/1988/11/18/us/female-sex-hormone-is-tied-to-ability-to-perform-tasks.html [Google Scholar]
  • 3.Mei G. This Letter to the Editor Argues Hillary Clinton Can’t Be President Because of “That Time of Month.” Cosmopolitan. 17 Oct 2016 [cited 2022 Feb 28]. Available from: https://www.cosmopolitan.com/politics/a6447296/letter-to-the-editor-hillary-clinton-period-stigma/. [Google Scholar]
  • 4.Sommer M, Sutherland C, Chandra-Mouli V. Putting menarche and girls into the global population health agenda. Reprod Health. 2015;1224. doi: 10.1186/s12978-015-0009-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Coutts LB, Berg DH. The portrayal of the menstruating woman in menstrual product advertisements. Health Care Women Int. 1993;14(2):179–91. doi: 10.1080/07399339309516039 [DOI] [PubMed] [Google Scholar]
  • 6.Gruer C, Hopper K, Smith RC, Kelly E, Maroko A, Sommer M. Seeking menstrual products: a qualitative exploration of the unmet menstrual needs of individuals experiencing homelessness in New York City. Reprod Health. 2021;18(1):77. doi: 10.1186/s12978-021-01133-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.van Eijk AM, Sivakami M, Thakkar MB, Bauman A, Laserson KF, Coates S, et al. Menstrual hygiene management among adolescent girls in India: a systematic review and meta-analysis. BMJ Open. 2016;6(3):e010290. doi: 10.1136/bmjopen-2015-010290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Munro AK, Hunter EC, Hossain SZ, Keep M. A systematic review of the menstrual experiences of university students and the impacts on their education: A global perspective. PLoS One. 2021;16(9):e0257333. doi: 10.1371/journal.pone.0257333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Coast E, Lattof SR, Strong J. Puberty and menstruation knowledge among young adolescents in low- and middle-income countries: a scoping review. Int J Public Health. 2019;64(2):293–304. doi: 10.1007/s00038-019-01209-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sommer B. How does menstruation affect cognitive competence and psychophysiological response?. Women Health. 1983;8(2–3):53–90. doi: 10.1300/J013v08n02_04 [DOI] [PubMed] [Google Scholar]
  • 11.Chrisler JC. Leaks, Lumps, and Lines. Psychology of Women Quarterly. 2011;35(2):202–14. doi: 10.1177/0361684310397698 [DOI] [Google Scholar]
  • 12.Phipps WE. The menstrual taboo in the Judeo-Christian tradition. J Relig Health. 1980;19(4):298–303. doi: 10.1007/BF00996252 [DOI] [PubMed] [Google Scholar]
  • 13.Davies SH, Langer MD, Klein A, Gonzalez-Hernandez G, Dowshen N. Adolescent Perceptions of Menstruation on Twitter: Opportunities for Advocacy and Education. J Adolesc Health. 2022;71(1):94–104. doi: 10.1016/j.jadohealth.2022.01.224 [DOI] [PubMed] [Google Scholar]
  • 14.Englander-Golden P, Whitmore MR, Dienstbier RA. Menstrual cycle as focus of study and self-reports of moods and behaviors. Motiv Emot. 1978;2(1):75–86. doi: 10.1007/bf00992733 [DOI] [Google Scholar]
  • 15.Kirstein L, Rosenberg B, Smith H. Cognitive changes during the menstrual cycle. Int J Psychiatry Med. 1980;10(4):339–46. doi: 10.2190/4k4f-gp08-xgdf-k13a [DOI] [PubMed] [Google Scholar]
  • 16.Moos RH. The development of a menstrual distress questionnaire. Psychosom Med. 1968;30(6):853–67. doi: 10.1097/00006842-196811000-00006 [DOI] [PubMed] [Google Scholar]
  • 17.De Bondt T, Jacquemyn Y, Van Hecke W, Sijbers J, Sunaert S, Parizel PM. Regional gray matter volume differences and sex-hormone correlations as a function of menstrual cycle phase and hormonal contraceptives use. Brain Res. 2013;153022–31. doi: 10.1016/j.brainres.2013.07.034 [DOI] [PubMed] [Google Scholar]
  • 18.Franke K, Hagemann G, Schleussner E, Gaser C. Changes of individual BrainAGE during the course of the menstrual cycle. Neuroimage. 2015;1151–6. doi: 10.1016/j.neuroimage.2015.04.036 [DOI] [PubMed] [Google Scholar]
  • 19.Ossewaarde L, van Wingen GA, Rijpkema M, Bäckström T, Hermans EJ, Fernández G. Menstrual cycle-related changes in amygdala morphology are associated with changes in stress sensitivity. Hum Brain Mapp. 2013;34(5):1187–93. doi: 10.1002/hbm.21502 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Tu C-H, Niddam DM, Yeh T-C, Lirng J-F, Cheng C-M, Chou C-C, et al. Menstrual pain is associated with rapid structural alterations in the brain. Pain. 2013;154(9):1718–24. doi: 10.1016/j.pain.2013.05.022 [DOI] [PubMed] [Google Scholar]
  • 21.Protopopescu X, Butler T, Pan H, Root J, Altemus M, Polanecsky M, et al. Hippocampal structural changes across the menstrual cycle. Hippocampus. 2008;18(10):985–8. doi: 10.1002/hipo.20468 [DOI] [PubMed] [Google Scholar]
  • 22.Lisofsky N, Lindenberger U, Kühn S. Amygdala/hippocampal activation during the menstrual cycle: evidence for lateralization of effects across different tasks. Neuropsychologia. 2015;6755–62. doi: 10.1016/j.neuropsychologia.2014.12.005 [DOI] [PubMed] [Google Scholar]
  • 23.Pletzer B, Harris T-A, Scheuringer A, Hidalgo-Lopez E. The cycling brain: menstrual cycle related fluctuations in hippocampal and fronto-striatal activation and connectivity during cognitive tasks. Neuropsychopharmacology. 2019;44(11):1867–75. doi: 10.1038/s41386-019-0435-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Schöning S, Engelien A, Kugel H, Schäfer S, Schiffbauer H, Zwitserlood P, et al. Functional anatomy of visuo-spatial working memory during mental rotation is influenced by sex, menstrual cycle, and sex steroid hormones. Neuropsychologia. 2007;45(14):3203–14. doi: 10.1016/j.neuropsychologia.2007.06.011 [DOI] [PubMed] [Google Scholar]
  • 25.Protopopescu X, Pan H, Altemus M, Tuescher O, Polanecsky M, McEwen B, et al. Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci U S A. 2005;102(44):16060–5. doi: 10.1073/pnas.0502818102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Zhuang J-Y, Wang J-X, Lei Q, Zhang W, Fan M. Neural Basis of Increased Cognitive Control of Impulsivity During the Mid-Luteal Phase Relative to the Late Follicular Phase of the Menstrual Cycle. Front Hum Neurosci. 2020;14568399. doi: 10.3389/fnhum.2020.568399 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Farage MA, Osborn TW, MacLean AB. Cognitive, sensory, and emotional changes associated with the menstrual cycle: a review. Arch Gynecol Obstet. 2008;278(4):299–307. doi: 10.1007/s00404-008-0708-2 [DOI] [PubMed] [Google Scholar]
  • 28.Seward GH. Psychological effects of the menstrual cycle on women workers. Psychological Bulletin. 1944;41(2):90–102. doi: 10.1037/h0057779 [DOI] [Google Scholar]
  • 29.Gamberale F. Effects of menstruation on work performance. Ergonomics. 1985;28(1):119–23. doi: 10.1080/00140138508963121 [DOI] [PubMed] [Google Scholar]
  • 30.Sherwin BB. Estrogen and cognitive functioning in women. Endocr Rev. 2003;24(2):133–51. doi: 10.1210/er.2001-0016 [DOI] [PubMed] [Google Scholar]
  • 31.Sommer B. The effect of menstruation on cognitive and perceptual-motor behavior: a review. Psychosom Med. 1973;35(6):515–34. doi: 10.1097/00006842-197311000-00007 [DOI] [PubMed] [Google Scholar]
  • 32.Sommer BA. Cognitive performance and the menstrual cycle. In: Richardson JTE, editor. Cognition and the Menstrual Cycle. New York, NY: Springer; 1992. pp. 39–66. Available from: doi: 10.1007/978-1-4613-9148-7_2 [DOI] [Google Scholar]
  • 33.Kimura D. Sex and cognition. Cambridge, MA: MIT Press; 2000.
  • 34.Sundström Poromaa I, Gingnell M. Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective. Front Neurosci. 2014;8:380. doi: 10.3389/fnins.2014.00380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ossewaarde L, Hermans EJ, van Wingen GA, Kooijman SC, Johansson I-M, Bäckström T, et al. Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle. Psychoneuroendocrinology. 2010;35(1):47–55. doi: 10.1016/j.psyneuen.2009.08.011 [DOI] [PubMed] [Google Scholar]
  • 36.Barbey AK, Koenigs M, Grafman J. Dorsolateral prefrontal contributions to human working memory. Cortex. 2013;49(5):1195–205. doi: 10.1016/j.cortex.2012.05.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338(4):209–16. doi: 10.1056/NEJM199801223380401 [DOI] [PubMed] [Google Scholar]
  • 38.Jang D, Elfenbein HA. Menstrual Cycle Effects on Mental Health Outcomes: A Meta-Analysis. Arch Suicide Res. 2019;23(2):312–32. doi: 10.1080/13811118.2018.1430638 [DOI] [PubMed] [Google Scholar]
  • 39.Koeske RD. Lifting the curse of menstruation: toward a feminist perspective on the menstrual cycle. Women Health. 1983;8(2–3):1–16. doi: 10.1300/J013v08n02_01 [DOI] [PubMed] [Google Scholar]
  • 40.Falleti MG, Maruff P, Burman P, Harris A. The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology. 2006;31(6):681–91. doi: 10.1016/j.psyneuen.2006.01.005 [DOI] [PubMed] [Google Scholar]
  • 41.Hunter JE, Schmidt FL. Methods of meta-analysis: correcting error and bias in research findings. Third edition. Thousand Oaks, California: SAGE; 2015.
  • 42.Meyer DE, Irwin DE, Osman AM, Kounios J. The dynamics of cognition and action: mental processes inferred from speed-accuracy decomposition. Psychol Rev. 1988;95(2):183–237. doi: 10.1037/0033-295x.95.2.183 [DOI] [PubMed] [Google Scholar]
  • 43.Schouten JF, Bekker JA. Reaction time and accuracy. Acta Psychologica. 1967;27143–53. doi: 10.1016/0001-6918(67)90054-6 [DOI] [PubMed] [Google Scholar]
  • 44.Wickelgren WA. Speed-accuracy tradeoff and information processing dynamics. Acta Psychologica. 1977;41(1):67–85. doi: 10.1016/0001-6918(77)90012-9 [DOI] [Google Scholar]
  • 45.Heitz RP. The speed-accuracy tradeoff: history, physiology, methodology, and behavior. Front Neurosci. 2014;8:150. doi: 10.3389/fnins.2014.00150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.van Maanen L. Is There Evidence for a Mixture of Processes in Speed-Accuracy Trade-Off Behavior?. Top Cogn Sci. 2016;8(1):279–90. doi: 10.1111/tops.12182 [DOI] [PubMed] [Google Scholar]
  • 47.Dutilh G, Wagenmakers E-J, Visser I, van der Maas HLJ. A phase transition model for the speed-accuracy trade-off in response time experiments. Cogn Sci. 2011;35(2):211–50. doi: 10.1111/j.1551-6709.2010.01147.x [DOI] [PubMed] [Google Scholar]
  • 48.Duncan MJ, Fowler N, George O, Joyce S, Hankey J. Mental fatigue negatively influences manual dexterity and anticipation timing but not repeated high-intensity exercise performance in trained adults. Res Sports Med. 2015;23(1):1–13. doi: 10.1080/15438627.2014.975811 [DOI] [PubMed] [Google Scholar]
  • 49.Le Mansec Y, Pageaux B, Nordez A, Dorel S, Jubeau M. Mental fatigue alters the speed and the accuracy of the ball in table tennis. J Sports Sci. 2018;36(23):2751–9. doi: 10.1080/02640414.2017.1418647 [DOI] [PubMed] [Google Scholar]
  • 50.Lee KA, Rittenhouse CA. Prevalence of perimenstrual symptoms in employed women. Women Health. 1991;17(3):17–32. doi: 10.1300/J013v17n03_02 [DOI] [PubMed] [Google Scholar]
  • 51.Li SH, Lloyd AR, Graham BM. Physical and mental fatigue across the menstrual cycle in women with and without generalised anxiety disorder. Horm Behav. 2020;118104667. doi: 10.1016/j.yhbeh.2019.104667 [DOI] [PubMed] [Google Scholar]
  • 52.Pallavi LC, D Souza UJ, Shivaprakash G. Assessment of Musculoskeletal Strength and Levels of Fatigue during Different Phases of Menstrual Cycle in Young Adults. J Clin Diagn Res. 2017;11(2):CC11–3. doi: 10.7860/JCDR/2017/24316.9408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12. doi: 10.1001/jama.283.15.2008 [DOI] [PubMed] [Google Scholar]
  • 54.Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn. 1990;14(1):26–43. doi: 10.1016/0278-2626(90)90058-v [DOI] [PubMed] [Google Scholar]
  • 55.Corporation for Digital Scholarship. Zotero. 2024. Available from: https://www.zotero.org/ [Google Scholar]
  • 56.Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological assessment. New York, NY, US: Oxford University Press; 2012. pp. xxv, 1161.
  • 57.Ussher JM, Wilding JM. Performance and state changes during the menstrual cycle, conceptualised within a broad band testing framework. Soc Sci Med. 1991;32(5):525–34. doi: 10.1016/0277-9536(91)90286-l [DOI] [PubMed] [Google Scholar]
  • 58.Riley JL 3rd, Robinson ME, Wise EA, Price D. A meta-analytic review of pain perception across the menstrual cycle. Pain. 1999;81(3):225–35. doi: 10.1016/S0304-3959(98)00258-9 [DOI] [PubMed] [Google Scholar]
  • 59.Reilly TJ, Sagnay de la Bastida VC, Joyce DW, Cullen AE, McGuire P. Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis. Schizophr Bull. 2020;46(1):78–90. doi: 10.1093/schbul/sbz030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Dunlap WP, Cortina JM, Vaslow JB, Burke MJ. Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods. 1996;1(2):170–7. doi: 10.1037/1082-989x.1.2.170 [DOI] [Google Scholar]
  • 61.Calamia M, Markon K, Tranel D. The robust reliability of neuropsychological measures: meta-analyses of test-retest correlations. Clin Neuropsychol. 2013;27(7):1077–105. doi: 10.1080/13854046.2013.809795 [DOI] [PubMed] [Google Scholar]
  • 62.Fitts DA. Commentary on “A review of effect sizes and their confidence intervals, Part I: The Cohen’s d family”: The degrees of freedom for paired samples designs. TQMP. 2020;16(4):281–94. doi: 10.20982/tqmp.16.4.p281 [DOI] [Google Scholar]
  • 63.Morris SB, DeShon RP. Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods. 2002;7(1):105–25. doi: 10.1037/1082-989x.7.1.105 [DOI] [PubMed] [Google Scholar]
  • 64.Arushanyan EB, Borovkova GK. Differences in monthly fluctuations of mental efficiency in healthy women depending on introversion/extroversion factor. Hum Physiol. 1993;19:68–70. [Google Scholar]
  • 65.Heister G, Landis T, Regard M, Schroeder-Heister P. Shift of functional cerebral asymmetry during the menstrual cycle. Neuropsychologia. 1989;27(6):871–80. doi: 10.1016/0028-3932(89)90010-9 [DOI] [PubMed] [Google Scholar]
  • 66.Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA: Sage Publications; 2001.
  • 67.Lederman MJ. Menstrual cycle and fluctuation in cognitive-perceptual performance. Doctoral dissertation, Boston University. 1974.
  • 68.Wiernik BM, Dahlke JA. Obtaining Unbiased Results in Meta-Analysis: The Importance of Correcting for Statistical Artifacts. Advances in Methods and Practices in Psychological Science. 2020;3(1):94–123. doi: 10.1177/2515245919885611 [DOI] [Google Scholar]
  • 69.Veith JL, Sandman CA, George JM, Stevens VC. Effects of MSH/ACTH 4--10 on memory, attention and endogenous hormone levels in women. Physiol Behav. 1978;20(1):43–50. doi: 10.1016/0031-9384(78)90201-9 [DOI] [PubMed] [Google Scholar]
  • 70.Saunders KEA, Hawton K. Suicidal behaviour and the menstrual cycle. Psychol Med. 2006;36(7):901–12. doi: 10.1017/S0033291706007392 [DOI] [PubMed] [Google Scholar]
  • 71.Blake KR, Dixson BJW, O’Dean SM, Denson TF. Standardized protocols for characterizing women’s fertility: A data-driven approach. Horm Behav. 2016;8174–83. doi: 10.1016/j.yhbeh.2016.03.004 [DOI] [PubMed] [Google Scholar]
  • 72.Broverman DM, Vogel W, Klaiber EL, Majcher D, Shea D, Paul V. Changes in cognitive task performance across the menstrual cycle. J Comp Physiol Psychol. 1981;95(4):646–54. doi: 10.1037/h0077796 [DOI] [PubMed] [Google Scholar]
  • 73.Griffin JW. Calculating statistical power for meta-analysis using metapower. TQMP. 2021;17(1):24–39. doi: 10.20982/tqmp.17.1.p024 [DOI] [Google Scholar]
  • 74.Hedges LV, Pigott TD. The power of statistical tests in meta-analysis. Psychol Methods. 2001;6(3):203–17. doi: 10.1037//1082-989x.6.3.203 [DOI] [PubMed] [Google Scholar]
  • 75.Hedges LV, Pigott TD. The power of statistical tests for moderators in meta-analysis. Psychol Methods. 2004;9(4):426–45. doi: 10.1037/1082-989X.9.4.426 [DOI] [PubMed] [Google Scholar]
  • 76.Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Routledge; 1988. doi: 10.4324/9780203771587 [DOI] [Google Scholar]
  • 77.Cohen J. A power primer. Psychol Bull. 1992;112(1):155–9. doi: 10.1037//0033-2909.112.1.155 [DOI] [PubMed] [Google Scholar]
  • 78.Atreya A, Nepal S. Untouchables: Women and Girls in Nepal. Obstet Gynecol. 2020;136(1):3–5. doi: 10.1097/AOG.0000000000003928 [DOI] [PubMed] [Google Scholar]
  • 79.Grandey AA, Gabriel AS, King EB. Tackling Taboo Topics: A Review of the Three Ms in Working Women’s Lives. Journal of Management. 2019;46(1):7–35. doi: 10.1177/0149206319857144 [DOI] [Google Scholar]
  • 80.Roberts T-A, Goldenberg JL, Power C, Pyszczynski T. “Feminine Protection”: The Effects of Menstruation on Attitudes Towards Women. Psychology of Women Quarterly. 2002;26(2):131–9. doi: 10.1111/1471-6402.00051 [DOI] [Google Scholar]
  • 81.LeBlanc VR. The effects of acute stress on performance: implications for health professions education. Acad Med. 2009;84(10 Suppl):S25-33. doi: 10.1097/ACM.0b013e3181b37b8f [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Ayman A Swelum

6 Oct 2024

PONE-D-24-40134Menstrual Cycle Effects on Cognitive Performance: A Meta-Analysis.PLOS ONE

Dear Dr. Jang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Please follow all reviewers recommendations and reply on their questions. 

==============================

Please submit your revised manuscript by Nov 20 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Ayman A. Swelum

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have referenced (unpublished) on page 10, which has currently not yet been accepted for publication. Please remove this from your References and amend this to state in the body of your manuscript: (ie “Bewick et al. [Unpublished]”) as detailed online in our guide for authors

http://journals.plos.org/plosone/s/submission-guidelines#loc-reference-style

3. Please respond by return e-mail with an updated version of your manuscript to amend either the abstract on the online submission form or the abstract in the manuscript so that they are identical. We can make any changes on your behalf.

4. As required by our policy on Data Availability, please ensure your manuscript or supplementary information includes the following:

A numbered table of all studies identified in the literature search, including those that were excluded from the analyses. 

For every excluded study, the table should list the reason(s) for exclusion. 

If any of the included studies are unpublished, include a link (URL) to the primary source or detailed information about how the content can be accessed.

A table of all data extracted from the primary research sources for the systematic review and/or meta-analysis. The table must include the following information for each study:

Name of data extractors and date of data extraction

Confirmation that the study was eligible to be included in the review. 

All data extracted from each study for the reported systematic review and/or meta-analysis that would be needed to replicate your analyses.

If data or supporting information were obtained from another source (e.g. correspondence with the author of the original research article), please provide the source of data and dates on which the data/information were obtained by your research group.

If applicable for your analysis, a table showing the completed risk of bias and quality/certainty assessments for each study or outcome.  Please ensure this is provided for each domain or parameter assessed. For example, if you used the Cochrane risk-of-bias tool for randomized trials, provide answers to each of the signalling questions for each study. If you used GRADE to assess certainty of evidence, provide judgements about each of the quality of evidence factor. This should be provided for each outcome. 

An explanation of how missing data were handled.

This information can be included in the main text, supplementary information, or relevant data repository. Please note that providing these underlying data is a requirement for publication in this journal, and if these data are not provided your manuscript might be rejected. 

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The meta-analysis presented by the authors demonstrates a clear and well-structured analysis of the available literature. It was written clearly, with standard English and a neutral tone.

The author did not mention about the type of oral contraceptive pills. Combined oral contraceptive pills mimic the natural cycle and progesterone-only pills include progesterone and suppress oestrogen levels. Without specifying which type of oral contraceptives were used in the included studies, it becomes difficult to interpret the findings in a meaningful way, especially when evaluating outcomes related to hormonal changes. I believe it would be better to clarify which type of oral contraceptive pills were used in the meta-analysis.

Why the authors felt aggregating the follicular, luteal and premenstrual phases was required? Follicular and luteal stages are completely two different hormonal stages of the menstrual cycle. Five-phase analysis is meaningful and it correlates with the physiological changes and hormonal status of the body.

The authors have clearly outlined the methodology, and their assessment of publication bias and limitations is comprehensive. The conclusion of the study would guide the policies and social justice for women.

Overall, this meta-analysis is well-executed, making it accessible and informative for readers.

Reviewer #2: I believe that the authors of this Systematic Review and meta-Analysis put much efforts in data collection, articles selection based on the outline measures, in acompay with statistical analysis to support the manuscrpt concepts.

However, some sections (methods, discussion and limitations sections) in this manuscript require certified English review, and Proof-Reading tools use to check again at grammer level.

Regarding the "Literature search strategy" at Methods section, the authors must clarify:

- The time limit for the collected raw articles /researches (i.e., up to Month, year) at the conducted search, and emphesize if being applied differently in one or more databases.

- the authors stated that 102 articles - met criteria for inclusion - out of 11,759 potential papers being collected were selected WITHOUT specialized software to conduct the literature search, and this cannot be rational due to absolute risk of selection bias and higher rates of removing possibly included articles. Besides, a de-duplication of all articles must be applied before screening by two reviewers. Thus, there MUST be a use of a validated reference software to handle and faciliate previously essential steps for articles screening and inclusion.

- Please note that "Not assessing individual studies for risk of bias, as it was not a part of the study design" is not accepted, because non-reporting biases lead to bias due to missing evidence in a systematic review. As well, Meta-analyses are at risk of bias due to missing evidence when results of some eligible studies are unavailable because of the P value, magnitude or direction of the results. Thus, the authors must provide a list of those 102 included studies, their design and corresponding Risk of bias assessment for each by referring the modified Cochrane Collaboration tools.

Reviewer #3: Dear Author,

Thank you very much for your contribution to science. The effort needed and methodology requires a very high training and time very valuable.

Going through the document, the style, redaction and contents are easy to read and understand. The explanation of limitations and methodology are complete and adapted to the type of study. It is well addressed that some steps of a systematic review and meta-analysis are not performed (e.g. study protocol, evaluation of the risk of bias in the studies included) and such there are some limitations pointed out in the study. I would like to address some points so it is considered to add some comments on this:

- More than 50% of studies included were published more than 20 years ago. Is it any specific support to consider they are comparable to more current situations? Social, cultural, environmental issues are very likely different, and so they can affect to cognitive habilities as well.

- The range of mean ages in the studies included is really wide. Considering menstrual cycle varies accross ages and occurrence of pregnancies, proximity to menarche or to perimenpause, among other situations, this constitutes a limitation too.

As I mentioned before, I consider limitations are generally well addressed and the perspective of using this knowledge to build new and better scientific production is appropriately indicated.

Reviewer #4: Congratulations to the authors for developing a manuscript that addresses a significant research gap in the field of women’s health. The study presents a clear and well-defined research objective and draws on a substantial volume of data, which holds great potential for generating meaningful conclusions. To further elevate the quality of the manuscript, I would like to offer the following suggestions for improvement.

1. The manuscript lacks consistency in how menstrual cycle phases are defined across different studies included in the meta-analysis. Relying on self-reports for phase identification can introduce bias, especially if hormonal confirmation is absent. It may be beneficial to provide a more consistent operational definition for menstrual cycle phases across studies. If hormonal confirmation is not available for all studies, I recommend including a section on how the variability in phase definition was handled and consider conducting sensitivity analyses to assess the impact of self-reported phase data. I believe this will strengthen the reliability of the results.

2. There is no clear indication that a power calculation was performed to ensure that the meta-analysis could detect small or moderate effects across the cognitive domains examined. To increase the robustness of the findings, I suggest including a formal power analysis. This would help determine whether the study was adequately powered to detect small or moderate effects across all cognitive domains.

3. The discussion of non-significant results is somewhat lacking in depth. While null findings are reported, the manuscript could benefit from a more comprehensive discussion of the possible reasons behind these results. I recommend expanding the discussion around the non-significant findings, especially by considering methodological differences between studies, small sample sizes, or other factors that could explain the lack of significant results. Providing more context will give readers a better understanding of these findings and their implications.

4. The manuscript does not adequately address how confounding variables (such as age, education, and socioeconomic status) were controlled in the meta-analysis or the original studies. It would be meaningful to include a section discussing whether the included studies controlled for specific confounders. If this information was not available, I suggest addressing the potential impact of these factors in the limitations section to strengthen the transparency of the analysis.

5. The two statistically significant results in spatial ability may be at risk of being over-interpreted, given the large number of comparisons conducted. Given the multiple comparisons made in this study, it would be prudent to apply more stringent correction methods (e.g., Bonferroni or FDR correction) to ensure the robustness of significant findings. Additionally, a more conservative interpretation of these results may help contextualize them more appropriately.

6. The results section could be clearer. While its written comprehensively, it may be overwhelming for readers, and the key findings may be buried in the details. I recommend summarizing the key results more clearly in the main text, possibly by creating a concise summary table or figure. Detailed data can be moved to supplementary materials, allowing readers to more easily follow the central findings.

7. The manuscript touches on the cultural and societal implications of menstrual cycle research but does not explore these in enough depth, particularly regarding the influence of external factors on women’s cognitive performance. I encourage expanding the discussion of how cultural and societal factors might influence women’s cognitive performance during their menstrual cycle. Exploring these broader implications would enrich the manuscript’s relevance and offer valuable context to the findings.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Mar 17;20(3):e0318576. doi: 10.1371/journal.pone.0318576.r003

Author response to Decision Letter 1


28 Nov 2024

Dear Dr. Swelum,

We thank you for the opportunity to revise our manuscript for further consideration at PLOS ONE.

Below, we address each of the issues pointed out by the reviewers as well as required by the journal.

Yours,

Daisung Jang

Melbourne Business School

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: We have followed PLOS ONE’s style requirements in the revision.

2. We note that you have referenced (unpublished) on page 10, which has currently not yet been accepted for publication. Please remove this from your References and amend this to state in the body of your manuscript: (ie “Bewick et al. [Unpublished]”) as detailed online in our guide for authors

http://journals.plos.org/plosone/s/submission-guidelines#loc-reference-style

Response: On page 10, we discuss our methods for the meta-analysis, which involves potentially including results from unpublished papers. We do not cite an unpublished paper in that section or elsewhere in the manuscript.

3. Please respond by return e-mail with an updated version of your manuscript to amend either the abstract on the online submission form or the abstract in the manuscript so that they are identical. We can make any changes on your behalf.

Response: Below is the version of the abstract for both the online submission form and the manuscript:

Does a woman’s cognitive performance change throughout her menstrual cycle? Menstruation continues to be a taboo topic, subject to myths about how it affects women. Despite the considerable number of empirical studies, there have been few quantitative summaries of what is known. To address this gap, we conducted a meta-analysis of cognitive performance across the menstrual cycle, including the domains of attention, creativity, executive functioning, intelligence, motor function, spatial ability, and verbal ability. We included studies that measured women’s performance at specific points in the cycle for tasks that have objectively correct responses. Our analysis examined performance differences across phases using Hedges’ g as the effect size metric. Across 102 articles, N = 3,943 participants, and 730 comparisons, we observe no systematic robust evidence for significant cycle shifts in performance across cognitive performance. Although two results appeared significant with respect to differences in spatial ability, they arise from a large number of statistical tests and are not supported in studies that use robust methods to determine cycle phase. Through the use of Egger’s test, and examination of funnel plots, we did not observe evidence of publication bias or small-study effects. We examined speed and accuracy measures separately within each domain, and no robust differences across phases appeared for either speed or accuracy. We conclude that the body of research in this meta-analysis does not support myths that women’s cognitive abilities change across the menstrual cycle. Future research should use larger sample sizes and consistent definitions of the menstrual cycle, using hormonal indicators to confirm cycle phase.

4. As required by our policy on Data Availability, please ensure your manuscript or supplementary information includes the following:

A numbered table of all studies identified in the literature search, including those that were excluded from the analyses.

Response: S10 Table contains a list of every paper included in the analyses. A list of every paper that was initially considered was not possible because we only retained bibliographic records of papers that passed a first relevance check for study domain. S11 Table also contains a list of papers that were excluded from the analyses that passed the relevance test but upon closer inspection did not contain sufficient data.

For every excluded study, the table should list the reason(s) for exclusion.

Response: We now better document the process by which papers were selected and updated Figure 1 to reflect this. We did not previously report the screening step prior to final analyses and do so in the revised version. S11 Table contains a list of papers that were excluded at the third selection because on closer inspection, they did not contain sufficient data, the measure of cognition was not classifiable, or the study did not operationalize the menstrual cycle in a way that could be used in the meta-analysis.

If any of the included studies are unpublished, include a link (URL) to the primary source or detailed information about how the content can be accessed.

Response: All manuscripts were either published or available on a dissertation database. We note this on page 11.

A table of all data extracted from the primary research sources for the systematic review and/or meta-analysis. The table must include the following information for each study:

Name of data extractors and date of data extraction

Response: The first author extracted all of the data. However, because specialized software was not used to conduct meta-analyses, date of data extraction was not recorded. We now note this on page 13.

Confirmation that the study was eligible to be included in the review.

Response: We note on page 15 that all studies included in the data analyses were eligible to be included in the review.

All data extracted from each study for the reported systematic review and/or meta-analysis that would be needed to replicate your analyses.

Response: All data required to replicate the study are presented in S1 Table. We note this on page 15.

If data or supporting information were obtained from another source (e.g. correspondence with the author of the original research article), please provide the source of data and dates on which the data/information were obtained by your research group.

Response: Data obtained from correspondence with an author of the original research article are recorded and dates when data were obtained are recorded in the notes of S1 Table.

If applicable for your analysis, a table showing the completed risk of bias and quality/certainty assessments for each study or outcome. Please ensure this is provided for each domain or parameter assessed. For example, if you used the Cochrane risk-of-bias tool for randomized trials, provide answers to each of the signaling questions for each study. If you used GRADE to assess certainty of evidence, provide judgements about each of the quality of evidence factor. This should be provided for each outcome.

Response: On page 30, we report publication bias through the examination of a funnel plot. We also conducted a formal test of publication bias, namely Egger’s test. It showed that funnel plot asymmetry was not significant (b = 0.025, t = -1.250, df = 1163, p = 0.212), indicating there was no evidence for small-study or publication bias.

An explanation of how missing data were handled.

Response: We did not attempt to impute any missing data. We note this on p. 15.

This information can be included in the main text, supplementary information, or relevant data repository. Please note that providing these underlying data is a requirement for publication in this journal, and if these data are not provided your manuscript might be rejected.

Reviewers' comments:

Reviewer's Responses to Questions

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The meta-analysis presented by the authors demonstrates a clear and well-structured analysis of the available literature. It was written clearly, with standard English and a neutral tone.

The author did not mention about the type of oral contraceptive pills. Combined oral contraceptive pills mimic the natural cycle and progesterone-only pills include progesterone and suppress oestrogen levels. Without specifying which type of oral contraceptives were used in the included studies, it becomes difficult to interpret the findings in a meaningful way, especially when evaluating outcomes related to hormonal changes. I believe it would be better to clarify which type of oral contraceptive pills were used in the meta-analysis.

Response: Thank you for your thoughtful comments. Unfortunately, of the twelve studies that recruited women using oral contraceptives (OC), seven did not report the type of oral contraceptive used. Of the five that did report OC types used by women, four did not report results by OC type. Within these samples, authors reported different kinds of OC being used by the recruited women. Only one study reported results by OC type. This made it impossible to meta-analyze outcomes related to specific OC formulation. We recognize this as a limitation of the study on page 37.

Why the authors felt aggregating the follicular, luteal and premenstrual phases was required? Follicular and luteal stages are completely two different hormonal stages of the menstrual cycle. Five-phase analysis is meaningful and it correlates with the physiological changes and hormonal status of the body.

Response: We thank the reviewer for this point and they are correct in that the five phase definition of the cycle appropriately separates the phases of the cycle. Thus, we focus our primary attention on analyses based on the five phase definition. The three phase definition does indeed aggregate different hormonal stages and we recognize that in the earlier version we did not provide sufficient justification for the aggregation. We chose to isolate the menstrual phase because it is readily detectable, and thus most accurately identified. We also isolated the ovulation phase because it is critical to reproduction and thus has theoretical implications. It is also detectable through multiple physiological tests (LH surge, body temperature shift). We sought to contrast these phases to the remainder of phases that may be less detectable, especially with respect to self-report or particular hormone markers. We explain this logic on pages 17-18 and appreciated the opportunity to clarify further the rationale behind the aggregation.

The authors have clearly outlined the methodology, and their assessment of publication bias and limitations is comprehensive. The conclusion of the study would guide the policies and social justice for women.

Overall, this meta-analysis is well-executed, making it accessible and informative for readers.

Response: We thank you for your helpful comments and for the opportunity to further strengthen the manuscript. Further, we appreciate your point about the value of this research for social justice.

Reviewer #2: I believe that the authors of this Systematic Review and meta-Analysis put much efforts in data collection, articles selection based on the outline measures, in acompay with statistical analysis to support the manuscript concepts.

However, some sections (methods, discussion and limitations sections) in this manuscript require certified English review, and Proof-Reading tools use to check again at grammer level.

Response: We thank you for your constructive comments and we have edited the manuscript with the assistance of a native English speaker.

Regarding the "Literature search strategy" at Methods section, the authors must clarify:

- The time limit for the collected raw articles /researches (i.e., up to Month, year) at the conducted search, and emphasize if being applied differently in one or more databases.

Response: We apologize for the misunderstanding and all databases we examined were searched for records as recent as January 2024. We clarify this on p. 11.

- the authors stated that 102 articles - met criteria for inclusion - out of 11,759 potential papers being collected were selected WITHOUT specialized software to conduct the literature search, and this cannot be rational due to absolute risk of selection bias and higher rates of removing possibly included articles. Besides, a de-duplication of all articles must be applied before screening by two reviewers. Thus, there MUST be a use of a validated reference software to handle and facilitate previously essential steps for articles screening and inclusion.

Response: We clarify our methodology further on page 11. Although we did not use specialized software to conduct a systematic search, we used citation management software (Zotero) to keep track of articles, both in terms of the originating database and in terms of managing duplicate entries. We apologize for the misunderstanding based on how we described the procedure.

- Please note that "Not assessing individual studies for risk of bias, as it was not a part of the study design" is not accepted, because non-reporting biases lead to bias due to missing evidence in a systematic review. As well, Meta-analyses are at risk of bias due to missing evidence when results of some eligible studies are unavailable because of the P value, magnitude or direction of the results. Thus, the authors must provide a list of those 102 included studies, their design and corresponding Risk of bias assessment for each by referring the modified Cochrane Collaboration tools.

Response: All articles analyzed in the meta-analysis are listed in S10 Table in the supplementary materials, and this is now mentioned on p. 30. Regarding the design of individual studies (e.g., methods used to track cycle, cross-sectional / longitudinal design / study site), these are listed on a per-sample basis in S1 Table. We analyze formally the risk of missing evidence (i.e., file drawer problem) through the examination of a funnel plot and through the use of Egger’s test for plot asymmetry (page 30), which revealed no evidence of publication bias.

Reviewer #3: Dear Author,

Thank you very much for your contribution to science. The effort needed and methodology requires a very high training and time very valuable.

Going through the document, the style, redaction and contents are easy to read and understand. The explanation of limitations and methodology are complete and adapted to the type of study. It is well addressed that some steps of a systematic review and meta-analysis are not performed (e.g. study protocol, evaluation of the risk of bias in the studies included) and such there are some limitations pointed out in the study. I would like to address some points so it is considered to add some comments on this:

Response: We thank you for your kind words and constructive comments.

- More than 50% of studies included were published more than 20 years ago. Is it any specific support to consider they are comparable to more current situations? Social, cultural, environmental issues are very likely different, and so they can affect cognitive abilities as well.

Response: We appreciate this thoughtful suggestion and in response engaged in additional analyses that examined studies conducted 20 years ago vis-a-vis those published more recently. At the end of this letter we provide a summary table analogous to Table 2 presented in the manuscript.

For studies conducted between 2004 and 2024, there were six significant differences in the overall and hormone confirmation subsets. Of those differences only one was adequately powered (i.e., sample size N = 273 or greater; see our response to reviewer 4, point 1), and involved samples that used hormone confirmation tests. However, when corrected for multiple comparisons, the p-value was no longer significant for that comparison (Phase 1 vs. remainder of phases for spatial ability accuracy).

For studies conducted in 2003 and earlier, there were more significant differences. They were observed in the domains of attention, memory, spatial ability, and verbal ability. Differences among hormone confirmation studies were observed for memory, with lower per

Attachment

Submitted filename: Response to Reviewers.docx

pone.0318576.s012.docx (317.6KB, docx)

Decision Letter 1

Ayman A Swelum

22 Dec 2024

PONE-D-24-40134R1Menstrual cycle effects on cognitive performance: A meta-analysis.PLOS ONE

Dear Dr. Jang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Please respond to the following reviewer who decide against publication of your manuscript. 

==============================

Please submit your revised manuscript by Feb 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Ayman A. Swelum

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #5: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #5: No

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #5: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #5: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I think the authors have fulfilled and well-explained all peer reviewers remarks and notes on the basis of clinical and scientific tracks, and made all the recommended corrections punctually.

Reviewer #5: I have read the authors' first version of the manuscript, the comments from the reviewers, and the revised version of the manuscript. In the revised version, the authors have addressed almost all the comments and suggestions made by the reviewers in the first round of review.

Overall, I appreciate their time and effort for preparing the study. In its revised form, the article still suffers in several fronts due to incorrect use of the terms, besides the methodological issues.

A main issue about the article is that nonsignificant results may be prone to more confounds compared to significant results. The number of data points is really very small for generalizability of the findings, despite there is no barrier against repeatability. The authors do mention some of these aspects in the limitations section; however, in case of acceptance (and in case I do not miss if it was already included) they are strongly recommended to add further information that show how many data points were used for calculating the statistics in Table 3.

As for the use of the terminology, the following statement seems to be an overgeneralization of the findings obtained in the literature. For instance, under the section "Evidence against fluctuations in cognitive ability across the cycle", they state that "The claim is that on tasks where women typically outscore men (i.e., verbal, motor, memory, and perception tasks), women perform better in the luteal phase. By contrast, on tasks where men typically outscore women (i.e., visual memory, mathematical ability, and spatial ability), women purportedly perform better during menses." Given the divergent findings, the authors should avoid using the term "typically outperform".

Another term appears in the title "Beliefs about the menstrual cycle". Belief is not an appropriate term when reporting the previous research. The authors may consider using an alternative term, such as "attitude" or "social aspects of...".

"In the following sections we survey existing academic research on the menstrual cycle and cognitive performance, ...": Remove the word academic.

"The hippocampus, a region associated with memory, increases ...": What does increase exactly, please make it clear (the grey matter).

"Accumulated evidence suggests that speed and accuracy decisions are based on accumulated information": Speed and accuracy are not "decisions" but usually performance measures, used as dependent variables.

The content of the section "Evidence for fluctuations in cognitive performance across the cycle" is not compatible with its title, as it is mostly about brain physiology, not cognitive performance. The authors mention the gap between the two in later sections; however, the section needs an improvement so that it introduces the research on cognitive performance rather than the findings on brain imaging. The following section has a similar tendency to address physiological-level findings more than the findings on cognitive performance. If that is a limitation observed in the literature, the authors should emphasize that.

It is necessary to clarify why there is a need for a meta-review on the topic, despite the presence of numerous reviews. The authors mention about it in the introductory sections; however, a discussion is needed in later sections to emphasize the added value of the conducted analysis. What is the contribution of the study, different than other systematic reviews and meta-reviews on the topic?

In case of acceptance, the authors are strongly recommended on the limitations of the methodology, such as the terms used for selecting the articles and the criteria behind the selection. For instance, they used the term "morphology" as a criterion for exclusion while selecting the article from Pubmed. Nevertheless, the introduction section has a long review of morphology.

The following statements are redundant (what is the added value? If needed, they can be given as supplementary information): "The first author, who holds an M.A. and Ph.D. in Organizational Behavior, conducted the literature search.", "The first author extracted all data from the articles and coded all variables."

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: No

Reviewer #5: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Mar 17;20(3):e0318576. doi: 10.1371/journal.pone.0318576.r005

Author response to Decision Letter 2


10 Jan 2025

Dear Dr. Swelum,

We thank you for the opportunity to further revise our manuscript for further consideration at PLOS ONE.

Below, we address each of the issues pointed out by the last reviewer.

Yours,

Daisung Jang

Melbourne Business School

Reviewer #5: I have read the authors' first version of the manuscript, the comments from the reviewers, and the revised version of the manuscript. In the revised version, the authors have addressed almost all the comments and suggestions made by the reviewers in the first round of review.

Overall, I appreciate their time and effort for preparing the study. In its revised form, the article still suffers in several fronts due to incorrect use of the terms, besides the methodological issues.

#1. A main issue about the article is that nonsignificant results may be prone to more confounds compared to significant results. The number of data points is really very small for generalizability of the findings, despite there is no barrier against repeatability. The authors do mention some of these aspects in the limitations section; however, in case of acceptance (and in case I do not miss if it was already included) they are strongly recommended to add further information that show how many data points were used for calculating the statistics in Table 3.

Response: We apologize for the confusion we created by limiting the results that were included in Table 3 vs. supplementary tables. Table 3 shows a summary of the full set of results. More detailed results are also presented as the reviewer requests, including number of studies, sample size, SE, confidence intervals, credible intervals, and heterogeneity statistics, which are shown in S2-S9 Tables. We now highlight this by changing the title of Table 3 to indicate that it contains summary results. In the notes section of the table, we now refer the reader to more detailed statistics in the supplementary tables. The reason for including the full statistics in supplementary tables only was to make the length of the manuscript manageable - S2 Table alone would take up 5 manuscript pages if included in the body of the text.

#2. As for the use of the terminology, the following statement seems to be an overgeneralization of the findings obtained in the literature. For instance, under the section "Evidence against fluctuations in cognitive ability across the cycle", they state that "The claim is that on tasks where women typically outscore men (i.e., verbal, motor, memory, and perception tasks), women perform better in the luteal phase. By contrast, on tasks where men typically outscore women (i.e., visual memory, mathematical ability, and spatial ability), women purportedly perform better during menses." Given the divergent findings, the authors should avoid using the term "typically outperform".

Response: We apologize for the potential overgeneralization introduced with the use of that term and have removed it from the revised manuscript.

#3. Another term appears in the title "Beliefs about the menstrual cycle". Belief is not an appropriate term when reporting the previous research. The authors may consider using an alternative term, such as "attitude" or "social aspects of...".

Response: We have replaced the word “Beliefs” with “Attitudes” throughout where appropriate.

#4. "In the following sections we survey existing academic research on the menstrual cycle and cognitive performance, ...": Remove the word academic.

Response: We have removed the word “academic”.

#5. "The hippocampus, a region associated with memory, increases ...": What does increase exactly, please make it clear (the grey matter).

Response: We have updated the section to read: “The grey matter volume in the hippocampus, a region associated with memory, increases from the premenstrual / follicular to later phases.”.

#6. "Accumulated evidence suggests that speed and accuracy decisions are based on accumulated information": Speed and accuracy are not "decisions" but usually performance measures, used as dependent variables.

Response: We have updated the section to read: "Evidence suggests that speed and accuracy performance are based on accumulated information".

#7. The content of the section "Evidence for fluctuations in cognitive performance across the cycle" is not compatible with its title, as it is mostly about brain physiology, not cognitive performance. The authors mention the gap between the two in later sections; however, the section needs an improvement so that it introduces the research on cognitive performance rather than the findings on brain imaging. The following section has a similar tendency to address physiological-level findings more than the findings on cognitive performance. If that is a limitation observed in the literature, the authors should emphasize that.

Response: We appreciate the reviewer pointing out this misalignment between the heading of the section and the content that follows. While clarifying the connection we discuss morphology to the extent that it has the potential to impact performance through secondary mechanisms. For example, changes in hippocampal volume throughout the cycle are accompanied by changes in neural connectivity (Lisofsky et al., 2015). On p. 5, we now discuss the significance of morphology before introducing research on the topic. We also note that there is a lack of research that directly addresses the case for or against shifts in cognitive performance across the cycle on p. 5.

#8. It is necessary to clarify why there is a need for a meta-review on the topic, despite the presence of numerous reviews. The authors mention about it in the introductory sections; however, a discussion is needed in later sections to emphasize the added value of the conducted analysis. What is the contribution of the study, different than other systematic reviews and meta-reviews on the topic?

Response: We thank the reviewer for the opportunity to further highlight the contribution of the manuscript and now include in the conclusion of the study (p. 37) a section that highlights the value of conducting a meta-analysis on the topic. A key methodological shortcoming of the existing literature is that most investigations utilize small sample sizes and a limited number of cognitive tasks, which makes claims about generalizability difficult. By summarizing the literature to date using a quantitative method, we are able to observe a larger picture of the role of the menstrual cycle in cognitive performance.

#9. In case of acceptance, the authors are strongly recommended on the limitations of the methodology, such as the terms used for selecting the articles and the criteria behind the selection. For instance, they used the term "morphology" as a criterion for exclusion while selecting the article from Pubmed. Nevertheless, the introduction section has a long review of morphology.

Response: As above in comment #7, we appreciate the reviewer noting the discrepancy between our discussion of morphology and demonstrated performance. We discussed morphology because it potentially contributes to performance via secondary mechanisms and now clarify why we excluded the term ‘morphology’ on p. 36—we were primarily interested in fluctuations of cognitive performance. For further responsiveness to the reviewer, on p. 36 we now discuss our methodological limitation that we only examine cognitive performance and not the underlying mechanisms of the performance. The discussion includes a suggestion that future research should identify potential mechanisms to advance theoretical understanding of this topic.

#10. The following statements are redundant (what is the added value? If needed, they can be given as supplementary information): "The first author, who holds an M.A. and Ph.D. in Organizational Behavior, conducted the literature search.", "The first author extracted all data from the articles and coded all variables."

Response: We listed the second statement in response to an editor's comment regarding the identity of the person who extracted the data. Data extraction is a separate step to the literature search in the MOOSE protocol (Stroup et al., 2000) we adhered to, hence identifying the person who conducted the search and extracted the data could potentially be different. The MOOSE protocol also requires the qualification of the person conducting the search to be listed in the manuscript. To respond to your comment regarding redundancy, we simplify the two statements to read: "The first author, who holds an M.A. and Ph.D. in Organizational Behavior, conducted the literature search, and extracted all data from the articles and coded all variables.".

References

Lisofsky, N., Mårtensson, J., Eckert, A., Lindenberger, U., Gallinat, J., & Kühn, S. (2015). Hippocampal volume and functional connectivity changes during the female menstrual cycle. NeuroImage, 118, 154–162. https://doi.org/10.1016/j.neuroimage.2015.06.012

Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Moher, D., Becker, B. J., Sipe, T. A., & Thacker, S. B. (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283(15), 2008–2012. https://doi.org/10.1001/jama.283.15.2008

Attachment

Submitted filename: Response to reviewers R2.docx

pone.0318576.s013.docx (318.9KB, docx)

Decision Letter 2

Ayman A Swelum

20 Jan 2025

Menstrual cycle effects on cognitive performance: A meta-analysis.

PONE-D-24-40134R2

Dear Dr. Daisung Jang,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ayman A. Swelum

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Ayman A Swelum

PONE-D-24-40134R2

PLOS ONE

Dear Dr. Jang,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Ayman A Swelum

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. List of studies, measures, and effect sizes.

    AO =  anovulatory, NC =  naturally cycling, OC =  oral contraceptives, BBT =  basal body temperature, L =  longitudinal, C =  cross-sectional, RBANS =  Repeatable Battery for the Assessment of Neuropsychological Status, WMS =  Wechsler memory scale, CVLT =  California verbal learning test, BVMT-R =  Brief Visuospatial Memory Test Revised, COWAT =  Controlled Oral Word Association Test, WAIS =  Wechsler Adult Intelligence Scale, WAIS-R =  Wechsler Adult Intelligence Scale-Revised, TTCT =  Torrance Tests of Creative Thinking, WJ III =  Woodcock-Johnson III Tests of Cognitive Abilities. aData obtained through correspondence, 7 Mar 2022. bData obtained through correspondence, 7 Mar 2022. cData obtained through correspondence, 17 May 2024. dData obtained through correspondence, 29 Jan 2022. eData obtained through correspondence, 18 Feb 2022.

    (XLSX)

    pone.0318576.s001.xlsx (92.5KB, xlsx)
    S2 Table. Meta-analyses of attention measures.

    All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

    (XLSX)

    pone.0318576.s002.xlsx (26.8KB, xlsx)
    S3 Table. Meta-analyses of creativity measures.

    All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

    (XLSX)

    pone.0318576.s003.xlsx (21.9KB, xlsx)
    S4 Table. Meta-analyses of executive function measures.

    All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

    (XLSX)

    pone.0318576.s004.xlsx (25.8KB, xlsx)
    S5 Table. Meta-analyses of intelligence measures.

    All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

    (XLSX)

    pone.0318576.s005.xlsx (21.3KB, xlsx)
    S6 Table. Meta-analyses of memory measures.

    All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

    (XLSX)

    pone.0318576.s006.xlsx (24.9KB, xlsx)
    S7 Table. Meta-analyses of motor function Measures.

    All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

    (XLSX)

    pone.0318576.s007.xlsx (22.9KB, xlsx)
    S8 Table. Meta-analyses of spatial ability measures.

    All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

    (XLSX)

    pone.0318576.s008.xlsx (26.7KB, xlsx)
    S9 Table. Meta-analyses of verbal ability measures.

    All values represent Hedges’ g effect sizes. P1 =  Menstrual phase, P2 =  Follicular phase, P3 =  Ovulatory phase, P4 =  Luteal phase, P5 =  Premenstrual phase.

    (XLSX)

    pone.0318576.s009.xlsx (22.5KB, xlsx)
    S10 Table. List of articles analysed in the meta-analysis.

    (XLSX)

    pone.0318576.s010.xlsx (20.2KB, xlsx)
    S11 Table. List of articles excluded from the meta-analysis.

    (XLSX)

    pone.0318576.s011.xlsx (14.7KB, xlsx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0318576.s012.docx (317.6KB, docx)
    Attachment

    Submitted filename: Response to reviewers R2.docx

    pone.0318576.s013.docx (318.9KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES